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ABSTRACT

Computational biophysics methods such as molecular dynamics (MD) simulations
are often used in combination with experimental techniques like neutron scattering,
NMR, and FTIR to explore protein conformational landscapes. With the
improvements in experimental techniques, there is also a need to continually
optimize the MD forcefield parameters to make precise predictions that match
experimental results. To complement many of these experiments, an accurate
model of deuteration is frequently required, but has been elusive. In our work, we
developed a novel method to capture isotope effects in classical MD simulations
by re-parameterization of the bonded terms of the CHARMM forcefield using
quantum mechanical (QM) calculations.
Apart from this, MD simulations can also be applied to explore a range of protein
motions over different timescales, which are otherwise experimentally challenging.
This work captures three such studies on protein dynamics- 1) the role of a) global
and b) local motions in facilitating ligand binding to various adhesin protein
homologs, and 2) a comparative study on the effect of temperature and pressure
changes on the dynamics of thermophilic and mesophilic pyrophosphatases. In the
case of adhesin proteins, we identified that the local motion in the loops near their
binding pockets is critical for ligand selectivity, whereas the global inter-domain
orientation in the protein is important for binding to the platelets. In the case of
pyrophosphatases, our studies revealed that the number of hydrogen bonds, in the
respective catalytic pockets of the two homologs, vary with temperature which
potentially causes the observed differences in their experimental enzymatic
activities.
Finally, another emerging application of computational biophysics is in the field of
therapeutic research, i.e., to identify new drugs and therapies to cure lethal
diseases by incorporating information about the target protein’s dynamics into
structure-based drug discovery. Implementing a pipeline that includes ensemble
v

docking and consensus scoring, we successfully targeted two proteins: 1) Histone
deacetylase (HDAC) 4 and 2) adhesin protein Hsa, which are known to cause
prostate cancer and infective endocarditis, respectively. For both the targets, we
identified multiple novel small molecules that also inhibit these proteins in-vitro.
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1 INTRODUCTION

1

1.1 Protein flexibility
Proteins are flexible macromolecules, and this flexibility is often the key
determinant for their biological functionality 1, 2. These functionalities range from
enzymatic catalysis and protein-protein interactions to even signaling and
transport1. The dynamics of a protein allow it to sample different conformations
and hence enable it to respond to changes in its environment, for example, pH 3
and

temperature

fluctuations4,

pressure

changes5,

6

,

and

even

the

presence/absence of binding partners (other proteins or small molecules)7, 8.
These responses to the environment could be driven by both local and global
motions. For instance, global motion like the domain movements in ABC
transporters9, cellular locomotion/motor proteins10, and in several enzymes like
glutamate dehydrogenase (GDH) 11 are critical for their functions. On the other
hand, local motion in proteins comprises the movement of side chains and loops,
and have been shown to be required for catalysis12, 13, for ligand binding, and even
for binding to other protein partners. Interestingly, these local and global motions
of a protein occur over a wide range of timescales from a few picoseconds to
hours1 (Fig 1.1). The fastest events like covalent bond vibrations and side-chain
rotations occur over a period of one femtosecond to a few picoseconds, whereas,
motions like secondary structure formation and loop movement occur over a
comparatively longer period of one nanosecond to a few microseconds. Similarly,
domain motions (the relative movement of domains in a multi-domain protein) can
take somewhere between a few nanoseconds to a few seconds to occur, whereas
protein folding can take up to an hour (Fig 1.1).

1.2 From Static to Ensemble
For a long time, protein structure has been considered to control the function of a
protein, which is commonly referred to as the structure-function relationship of a
protein14, 15. However, in the last decade, researchers have provided considerable
support suggesting that the dynamics/motion of a protein is also critical for its
function, such that a protein exists as an ensemble 16 of inter-converting structures
2

rather than a single structural conformation and the dynamics/motions enabling
this interconversion are also critical for protein function 17-20. In an ensemble, each
conformation of the protein has an associated free energy (which determines its
stability), that can be represented by a point on the resulting free energy landscape
(FEL) of the entire protein ensemble 21 (Fig 1.2). This idea of the FEL is a wellestablished concept in the field of protein folding 22-24 and has also been used to
define the protein-solvent system25-27. The FEL of a protein characterizes two
properties of the system – 1) thermodynamic (i.e., the relative probabilities of the
conformational states) and 2) kinetic (i.e., the free energy barrier between these
conformational states), both of which are crucial for understanding protein
dynamics1, 28.
Studying the FEL of a protein has shown that the states with lower free energy
have more favorable conformations, but these states can often transition to other
conformations depending on the ambient conditions or as a result of their biological
function19-21,

25, 29

. Hence, the FEL of a protein is largely a rugged space with

different free energy wells resulting in different conformations (or transient
microstates) separated by barriers that strongly correlate with timescales/kinetics
of protein function19-21, 25, 29, 30 (Fig 1.2). Therefore, understanding how a protein
explores its FEL over the course of time and how it responds to changes in the
environment is very important for a complete description of its function.

3

ps

Side-chain rotation
0.1 ps – 10 ps

µs

Enzymatic catalysis
1 µs – 1 s

ns

Secondary structure
formation
10 ns – 1 ms

ms

s

Protein folding
1 ms – 1 hr

>min

Domain motion
1 ns – 1 s

Loop movement
1 ns – 1 ms

Figure 1.1 Schematic representation of various protein motions at different
time scales.

4

Figure 1.2 Representative image showing the free energy landscape of a
protein with multiple minima. Each well corresponds to a minimum energy
conformation and the arrows represent the transition states. Adapted from
ref31.

5

1.3 Exploring the protein free energy landscape
Since the first protein structure was determined by X-ray crystallography in the late
1950s, the number of protein crystal structures has increased exponentially over
the last two decades32. Apart from X-ray crystallography, numerous advancements
have also been made in other structure determination techniques such as highthroughput time-resolved X-ray crystallography33-36, cryo-Electron Microscopy
(Cryo-EM)37-39, Mass spectrometry, Nuclear Magnetic Resonance (NMR)40-44, and
Small Angle X-ray Scattering (SAXS)45-47. These developments have enabled
researchers to even resolve the structures of complex systems, which has
otherwise been extremely challenging48. Despite these improvements in
experimental techniques, the exploration of the complete free energy landscape of
protein conformations at an atomistic detail has still not been achieved48. Computer
simulations (like MD simulation), on the other hand, can be used to broadly sample
the conformational space of a protein system and provide the required spatial and
temporal information at an atomic resolution, which has been difficult to access
experimentally49,

50

. Additionally, this information can further be combined with

experimental methods, described above, to attain a complete picture of the protein
energy landscape51-53.

1.4 Molecular Dynamics simulation
There are a range of different computer simulation techniques available for the
study of protein structures and dynamics. Techniques such as energy minimization
and Monte Carlo (MC) simulations do not rely on the equations of motion, and
hence fail to provide direct information about the dynamics of a protein system54.
On the contrary, methods such as Brownian Dynamics (BD) 55, 56 and Molecular
Dynamics (MD) calculate the positions and momenta of all particles in a system as
a function of time by integrating the equations of motion in discrete time steps and
therefore are applied to generate information about protein dynamics 54. Among
these different simulation techniques, MD is the most commonly used method in
the field of biomolecules (like protein, DNA, RNA) because it can closely replicate
6

experimental observations and can also capture a range of timescales and
motions50. In MD, atomic motion is simulated by solving Newton's equations of
motion, and this can be applied to obtain both thermodynamic and kinetic
properties of a biomolecule (i.e., ligand binding to enzymes, protein assembly,
transport through a channel and so on) 50.
Mechanistically, in MD, the atoms are considered as classical particles, where the
electrons are not treated explicitly. The separation between electronic and nuclear
motions is justified by the Born-Oppenheimer (BO) approximation (BO states that
if all the electrons are relaxed in their ground state configuration, then they can be
assumed to be fixed on the nuclei)54. Therefore, in MD, the atoms are considered
as inert spheres, and the bonds/vibrations are represented as springs between two
spheres. Additionally, in MD, the inter- and intra- atomic forces between the atoms
are calculated using a "potential", which are collectively referred to as molecular
mechanics (MM) force fields54. A typical MM force field potential function
incorporates van der Waals and coulombic electrostatic forces for the non-bonded
part of the potential function and harmonic energy function for bonded interactions
(i.e., bonds, angles, dihedrals) 54. Generally, the timestep between MD simulation
is in femtoseconds (fs), and the interactions between atoms of the system are
computed for ns -μs timescales. The most commonly used MM forcefields to study
biomolecules are AMBER 57, 58, CHARMM59, 60, GROMOS61, OPLS62. However,
there are some challenges to these force fields especially in the accurate modeling
of intrinsically disordered proteins and in incorporating the effects of charge
polarization63. Therefore, there is a need to continually improve the MD forcefield
parameters to not only make more accurate predictions that match experimental
results but also to overcome current limitations.
One such limitation is an incomplete representation or the absence of specific force
field parameters for deuterated molecules. Accurate modeling of deuterated
molecules is critical for multiple studies, especially because MD is often used in
conjunction with experiments such as neutron scattering64, 65, NMR66, and FT-IR67,
which usually require an accurate model of deuteration to complement these
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experiments. To this end, we have addressed this issue and developed a novel
method for parametrizing deuterated molecules in Chapter 2.
Apart from employing an accurate MM force field, simulation protocol has several
basic steps, which include: 1) System preparation, 2) Minimization/Relaxation, 3)
Equilibration and 4) Production (Fig 1.3). The respective parameters for each step
mentioned above are specific to each protein, and individual details will be
documented in each of the following chapters.

1.5 Enhanced sampling simulation
Although classical MD simulations are regularly employed to study most biological
systems of interest, the total simulation time is usually restricted to a few hundred
ns to a µs because of the requirement for extensive computing resources. Since a
protein exhibits different types of motions and that some of them occur at
timescales beyond a microsecond, classical MD cannot always capture the entire
dynamics of a protein. Furthermore, in many cases, the FEL of a protein has
multiple potential energy wells (or minima) with high free energy barriers, and it is
quite likely for a system to get trapped in one or another local minimum for long
periods of simulation time thus preventing accurate exploration of FEL. Hence, to
allow the exploration of multiple minima in a rugged FEL, modified simulation
methods known as “enhanced” sampling techniques have been developed. These
methods use certain biases (for example, modification of the potential energy
surface by adding bias potential to decrease the energy barrier) to accelerate the
escape from a local free energy minimum enabling greater exploration of
conformational space. Within enhanced sampling, multiple methods exist, of these
the most popular enhanced sampling methods are: a) Replica Exchange Molecular
Dynamics (REMD)- enhances the sampling by allowing systems of similar potential
energies to sample conformations at different temperatures 68, 69 or variations in a
Hamiltonian (HREMD), therefore, overcoming the energy barriers on the potential
energy surface; b) Metadynamics (MetaD)- enhances the sampling by
reconstructing the free-energy surface as a function of few selected degrees of
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freedom or collective variables (CVs)70, 71; and c) accelerated Molecular Dynamics
(aMD)72, 73 - enhances the sampling by defining a simple and robust bias potential
using boost factor which flattens the energy landscape. All these methods have
their advantages and limitations, and their usage often depends on the
biomolecular system and the biochemical phenomena under investigation.

1.6 Protein dynamics in drug discovery
Along with understanding protein functionality, protein dynamics are also critical
for drug discovery research. A majority of approved drugs in the market target a
protein in the mammalian system, hence necessitating a need for a concrete
understanding of protein structures and their functional mechanisms to develop
new drugs. This process, also known as structure-based drug design (SBDD),
started in the late 1970s soon after the first crystallographic protein structure was
resolved. Researchers realized that studying the protein structure can lead to a
‘‘rational’’ drug design, and that one can mimic the ligand/drug binding process in
silico by docking potential ligands (generally small molecules) to protein targets in
three dimensions74. The early docking studies were very successful and have led
to the discovery of antivirals for HIV and influenza 75, 76. For a long time, however,
a single protein structure, often the crystal structure, was used for docking of small
molecules, but ever since the dynamic picture of the protein has been accepted 77,
a new research avenue of including protein dynamics in light of drug discovery
have emerged to better target the proteins of interest 78. This process of including
an ensemble of protein structures instead of one conformation for docking is
commonly referred to as Ensemble docking 78 (Fig. 1.4). This ensemble of
structures for a protein can be generated from MD simulation(s). Previous studies
have shown that this process of using multiple conformations of a protein is
important because the shape of the binding pocket can change during the course
of the simulation and this would be missed if a single structure was used. Since
receptor shape complementarity is one of the important criteria in docking
protocols, this approach can lead to the identification of additional molecules
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binding in the same pocket74, 79. Moreover, previous research has also shown that
novel and functionally relevant pockets appear during the course of the
simulation80, 81, which are not present in the initial static structure, and these pave
a path to develop newer strategies to target the protein of interest.

1.7 Early stage drug discovery pipeline
Discovery and development of a drug is a time and resource-intensive process.
There is thus a growing effort to apply alternative approaches to the combined
space of chemistry and biology to modernize drug discovery, design, development,
and optimization process82. A promising approach is to harness the everincreasing computational power to the plaguing problem of novel drug
development, as mentioned above 83. The stage where computational power has
been monumental in speeding up the drug discovery process is the initial hit
identification process83. This in-silico hit discovery or computer-aided drug
discovery (CADD) pipeline consists of multiple different steps as described below
and shown in Fig 1.5:

1) Target identification and validation: The first step of a CADD pipeline
involves the identification of potential therapeutic targets (mostly proteins)
by investigating their functions and association with specific diseases. This
step is the most critical step and requires extensive support of experimental
studies82.
2) Protein structure/s: Once the protein target has been identified,
knowledge of the protein structure is necessary for CADD. The two common
approaches to get the initial structures of the protein are: a) crystal structure
and b) homology modeling84. In homology modeling, a known crystal
structure of a homologous protein is used as a template to build the
structure using an array of in silico tools. In the absence of a homologous
crystal structure, ab-initio modeling is performed. In the case of “ensemble”
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docking, an extensive MD is the performed on the initial structure to get an
ensemble of conformations.

3) Binding site prediction: After getting the ensemble of protein
conformations, the binding site or docking site is identified. The binding sites
are mostly pockets or cavities, and there are several tools such as FTMAP 85
and MOE Site Finder86 that can be used to predict these sites. In the case
of a competitive inhibitor (i.e., an inhibitor which competes with the native
ligand/substrate), this step is often not required since the site is already
known. For example, an inhibitor for an enzyme would compete for the
substrate binding site in its catalytic pocket and hence site prediction using
advanced tools would not be required.
4) Docking: After getting the ensemble of protein conformations and the site
of interest, the next step is to dock a database of small molecules (such as
ZINC87, Enamine88, NCI) using docking tools such as Autodock4 89,
AutodockVina90, MOE86, etc. to identify the molecules that bind the target
protein at the site of interest. Different docking protocols use different
scoring functions and search strategies to dock the small molecules.
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System preparation
To build a starting structure, solvating, applying a force field, etc.

Minimization/Relaxation
To find a local energy minimum of the starting structure

Equilibration
To bring the system to the appropriate state
point (e.g. target energy, temperature and
pressure)

Production
To retain and analyze the collected data

Figure 1.3 Flowchart showing different steps of a molecular dynamics
simulation: 1) System preparation; 2) Minimization/Relaxation; 3)
Equilibration and 4) Production
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Figure 1.4 Ensemble docking: A cartoon showing multiple protein
conformations targeted with small molecules.
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5) Scoring: Once docking has been performed and multiple docked poses
have been produced, the next step is to prioritize them and generate a
ranked list of the compounds such that compounds with better scores (or
better affinity) get a higher rank and are listed first. This is often done based
on scores given by the different docking tools by approximating the free
energy of binding. Another optional step after obtaining the prioritized list of
small molecules is consensus docking. In this step, the docked poses can
be re-scored using an additional scoring function to get another prioritized
list, and then a consensus of both is used as the final ranked list. This
approach is usually a powerful addition and has been shown to improve the
hit rate and also reduce the number of false positives.

6) Experimental validation: The last step for the hit discovery pipeline is
experimental validation. Here, based on the ranked list, priority compounds
are selected to determine their binding to target protein, which is preferably
performed in-vitro using techniques such as Surface plasma resonance
(SPR), ITC, fluorescence assay, etc82.

This CADD approach not only greatly reduces the number of molecules for
experimental screening, which require extensive labor and resources but also
provides a more rational approach to the traditional brute-force method of
experimental testing83. After the initial hits are identified, the next steps in the drug
discovery pipeline are hit expansion or lead optimization where the hit molecules
are further modified to make them more selective and to satisfy ADME (Absorption,
Distribution, Metabolism, and Excretion) criteria 91. This is then followed by a threephase clinical trial and approval. Traditionally, the whole drug discovery process
can take between 10-12 years, from target identification to FDA approval 82.
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Validation
(experimental assay)
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Figure 1.5 Drug discovery pipeline
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1.8 Proposed study
Protein dynamics are critical to understand the function of a protein. Computer
simulations have emerged as very powerful tools to uncover the mechanism of
function and stability of a protein. In this dissertation, I have used an array of
computational simulation methods to study different types of protein dynamics in
multiple proteins of interest. This work was further expanded to apply the results
in early-stage drug discovery. Specifically, in Chapter 2, I studied the pitfalls of
existing force fields to accurately represent deuterated molecules and successfully
developed a strategy to overcome this limitation. In Chapter 3, we studied the
protein dynamics of adhesin proteins and characterized the functional relevance
of global motions (like domain motion) and local motions (like loop motion) in the
binding pocket. In Chapter 4, I studied the effect of temperature and pressure on
protein dynamics and enzymatic function in inorganic pyrophosphatases from
mesophilic and thermophilic organisms. Lastly, in Chapter 5, I applied the
knowledge of protein dynamics to perform ensemble docking on two clinically
relevant protein targets: adhesin protein Hsa and histone deacetylase 4 (HDAC4).
Using a combination of computer simulations, ensemble docking, and
experimental validations, I have successfully identified hits for both these target
proteins.
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Figure 1.6 Dissertation division into chapters
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2 PARAMETERIZATION OF SMALL DEUTERATED
MOLECULES
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A version of this chapter was originally published by me:
Agarwal, Rupesh, Micholas Dean Smith, and Jeremy C. Smith. "Capturing
Deuteration Effects in a Molecular Mechanics Force Field: Deuterated THF and
the THF–Water Miscibility Gap." Journal of Chemical Theory and Computation
16.4 (2020): 2529-2540.
In this work, I executed the research, performed analyses, and wrote the paper.
Dr. Micholas Dean Smith conceived the idea and made substantive contributions
to the manuscript’s content and Dr. Jeremy C. Smith helped in the discussion of
results and edited the manuscript.

2.1 Abstract
Deuteration is a common chemical modification used in conjunction with
experiments such as neutron scattering, NMR, and FT-IR for the study of
molecular systems. Under the Born-Oppenheimer (BO) approximation, while the
underlying potential energy surface remains unchanged by isotopic substitutions,
isotopic substitution still alters intra-molecular vibrations, which in turn may alter
inter-molecular interactions. Molecular mechanics (MM) force fields used in
classical molecular dynamics (MD) simulations are assumed to represent local
approximations of the BO potential energy surfaces, and hence MD simulations
using simple isotopic mass substitutions should capture BO-compatible isotope
effects. However, standard MM force-field parameterizations, do not directly fit to
the local harmonic quantum mechanical (QM) Hessian that describes the BO
surface, but rather to QM normal-modes and/or mass-dependent internalcoordinate derived distortion energies. Here, using THF-Water mixtures as our
model system, we show that not only does a simple mass-substitution approach
fail to capture an experimentally characterized deuteration effect (the loss of the
closed-loop miscibility gap associated with the complete deuteration of THF), but
that it is necessary to generate new MM force-field parameters that correctly
describe isotopic dependent vibrations to capture the experimental deuteration
effect. We show that the origin of this failure is a result of using mass-dependent
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features to fit the THF MM force-field, which unintentionally biases the bonded
terms of the force-field to represent only the isotopologue used during the original
force-field parameterization. In addition, we make use of our isotopologue
corrected force-field for D8THF to examine the molecular origins of the isotopedependent loss of the THF-water miscibility gap.

2.2 Introduction
The use of hydrogen/deuterium (H/D) isotope substitution to probe the structure
and dynamics of molecular systems is well established, with applications including
neutron scattering92-94, NMR95, 96, FT-IR97-101, and others102-104. Deuteration is well
known to change hydrogen bonding 105, 106, vibrational dynamics107, 108, reaction
kinetics109, 110, and phase behavior111-113.
For decades molecular dynamics (MD) simulation has been used in combination
with experiment to provide atomic-resolution descriptions of isotope effects in small
molecular systems 114-116. Explicit studies of deuteration have, traditionally,
required the use of Path-Integral Molecular Dynamics (PIMD)

117-119

or Quantum

Trajectory/Dynamics (QMD) approaches120, which for large molecular systems
remains computationally expensive. Although both PIMD and QMD, in principle,
provide a means to completely capture the impact of deuteration on the dynamics,
it is important to consider that although the quantum nature of the nuclei is changed
upon deuteration, cheaper calculations that make use of the Born-Oppenheimer
(BO) approximation also exhibit isotope dependencies 121, 122. Indeed, while the
potential energy surface (PES) of a molecular system is invariant of mass, within
the BO approximation, the dynamics of system is altered by isotopic substitution
(via mass-dependent changes to the kinetic energy operator)121, 122. Given that
dynamics on the BO PES are altered, a computationally cheap means of studying
the impacts of isotopic substitution phenomena, where the quantum nature of the
nuclei may be hypothesized to be unimportant, would be to perform traditional
molecular dynamics on the BO surface with the appropriate mass weighting.

20

Classical MD simulations using typical classical class I and/or biomolecular
molecular mechanics (MM) force-fields are parameterized to represent a local
harmonic approximation of Quantum Mechanics (QM) derived BO PES 54, 123 by
fitting to QM vibrational analyses and (when available) experimental geometries
and

thermodynamic

quantities.

In

the

absence

of

experimental

geometries/thermodynamics, QM geometry optimization and vibration calculations
are used to obtain starting guesses for the equilibrium geometry of the system of
interest and the force-constants that describe the intra-molecular dynamics of the
system. During the QM vibrational analysis, the decoupling between the
translational and rotational degrees of freedom of the molecular system is required.
This decoupling is achieved via the use of a mass-dependent coordinate system
that is constructed to satisfy the Eckart-Sayvetz conditions121. Essentially this
isotopic dependence of the QM vibrational analysis implies that normal modes and
distortion energies (computed along the internal coordinates derived to satisfy the
Eckart-Sayvetz conditions), which are used to fit the MM bonded terms, may carry
an implicit isotopic dependence. This indicates that MM force-fields themselves
may not necessarily reflect a classical approximation of the BO PES, but rather
isotopic specific dynamics on the BO PES. We hypothesize that 1) this isotopic
dependence does exist and as a result a simple (naïve) substitution of different
isotopic masses in the MM force-fields used in MD simulations would fail to capture
accurate isotopic intra-molecular dynamics; 2) if the MM force-field is reparameterized using properly weighted QM vibrational analyses derived features
using the isotopic masses of interest it would be possible to accurately capture
isotope dependent intra-molecular vibrations and in turn accurately capture
isotope-dependent inter-molecular interactions.
To test these two hypotheses, we study the macroscopic behavior of the miscibility
gap between tetrahydrofuran (THF) and water. THF is a ubiquitous, heterocyclic
organic solvent with applications ranging from organometallic chemistry 124 and
polymer synthesis125-128 to NMR spectroscopy129 and lignocellulosic biomass
pretreatment (when used as a co-solvent)130-136. Along with these uses, THF, when
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mixed with water, serves as a model system for the investigation of a mixture
exhibiting a closed-loop miscibility gap (a miscibility gap with two critical
temperatures)112, 137. This miscibility gap occurs in mixtures of fully hydrogenated
THF and water with mass ratios ranging from ~0.3 to 2.8 and at temperatures
above ~71 °C and below ~137 °C. At these conditions, THF and water have been
shown experimentally112, 113, 138 and computationally (at timescales on the order of
tens of nanoseconds)139, 140 to spontaneously de-mix, whereas outside of these
ranges, they remain mixed. Most interesting for the present study of isotope
effects; however, is that upon complete H/D substitution of THF (i.e., D 8THF), this
miscibility gap disappears112, 113.
Prior experimental work on (hydrogenated) THF-water solutions has indicated that
small-scale phase separation occurs even at temperatures outside of the
miscibility gap, resulting in the presence of both micro-voids and THF-rich
domains141-143. Furthermore, computational studies have reported that within the
miscibility gap temperature regime prior to phase separation, the diffusivities of the
two species diverge140. However, despite these micro-domains and variations in
diffusion, THF and water mixtures contain a significant population of mutual
hydrogen bonds (between the oxygen atoms of THF and the hydrogen atoms of
water) while largely preserving water-water hydrogen bonding141. Given these
competing tendencies, it has been hypothesized that THF-water hydrogen-bonds
are necessary for the two solvents to remain mixed 141-143. And, it was recently
suggested that the onset of the miscibility gap is due to mismatches in the rate of
change (as a function of temperature) of THF-water and water-water hydrogenbonding and THF-THF, THF-water, and water-water interactions140. While these
studies have advanced our understanding of the molecular origins of THF-water
miscibility gap, the underpinnings of the peculiar influence of isotopic substitution
on the gap remain unclear. Additionally, two points that justify the choice of the
THF-water system as the model system to explore potential implicit isotopic effects
are: 1) prior simulations have demonstrated the it is possible to simulate THF-water
phase separation within sub-microsecond timescales139,
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140

, suggesting the

macroscopic phase behavior can be readily simulated with current computational
resources, and 2) given the isotopic substitution occurring in deuterated THF is at
the sites of non-polar hydrogens (i.e., hydrogen atoms that do not form intermolecular hydrogen-bonds), the isotope-dependent phase separation phenomena
is not likely driven by non-local nuclear quantum effects, suggesting that an
accurate classical approach should be able to capture the isotope-dependent
behavior of the system.
The work reported here thus addresses two questions: 1) Does the standard MM
force-field contain implicit isotopic biases, and, if so, can a re-parameterization
approach provide a means to overcome this bias for classical MD simulations? and
2) what is the origin of the loss of the THF-water miscibility gap upon deuteration?

2.3 Methods
Several MD simulation campaigns of different THF-water systems were performed
to examine substitution and re-parameterization approaches to capturing
deuteration within classical simulations. All of the simulation calculations were
carried out using the GROMACS (version 2016.3) simulation suite 144,

145

, and

analysis was performed using a combination of in-house VMD Tcl scripts and
GROMACS analysis tools. Center-of-mass radial distribution functions (RDFs),
site-specific coordination numbers, hydrogen bonds (HB), and diffusion constants
were calculated. Additionally, for the re-parameterization approach, we have the
ancillary aim of providing force-field parameters, which may be of use in other
studies, and as such, we restricted ourselves to the development of parameters
for completely deuterated THF (D8THF) that are compatible with the CHARMM
potential146.
Details of the various simulations, the deuteration parameterization method and
analyses of trajectories are provided in the sections below.
Model systems
All simulations were performed using the CHARMM potential 146 on four systems
for which the parameters that describe THF vary:
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i)

with

THF

represented

by

the

CHARMM32

ether

force-

field147,denoted as THF.
ii)

with the mass of each hydrogen doubled (the traditional mass
substitution method), but no changes in the force-field parameters
i.e., “heavy” THF, denoted as HTHF,

iii)

with both the masses of the hydrogen atoms doubled and the
bonded parameters re-parametrized (see parameterization details
below) denoted as D8THF,

iv)

with bonded parameters of hydrogenated THF calculated using the
same methodology as (iii), denoted THFK.

D8THF Parameterization
As noted above, we consider two possible approaches for capturing isotope effects
in classical MD:
i)

‘Substitution’ approach: increasing the mass of hydrogen to 2.014u
while preserving all force-field parameters (here we use the
CHARMM32 ether force-field147 parameters) of the hydrogenated
molecule, and

ii)

Re-parameterization approach: by which the new force-field
parameters are generated using the mass of deuterium in place of
hydrogen during the fitting of bonded (bonds, angles, and dihedrals)
force-field parameters. It should be noted that a prior attempt to
capture isotope effects in a classical manner (beyond the mass
substitution approach) has been reported in the literature: a
parameter-scaling modification to the MM2 force-field where van der
Waals interactions and bond-lengths were altered to reflect H/D size
differences148. Although this attempt was reasonably successful
failures were noted for heterocyclic compounds.

At this point it is helpful to recall that the bonded terms of molecular mechanics
force-fields are frequently obtained via fitting to the mass-dependent quantities)149
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(see Introduction). By substituting the mass of deuterium for hydrogen during the
QM frequency calculations and then fitting new force-field parameters using
distortion energies derived from mass-weighted internal coordinates, as is done in
the FFTK150 parameterization protocol, we expect to obtain a parameterization that
capture the energetics of the deuterated isotopologues of interest. In principle, the
re-parameterization method aims to derive classical force-field parameters that
better reflect how given an unchanged PES (as the BO surface is invariant to
isotopic substitutions), the frequencies and vibrational modes for the nuclei, are
altered as a result of the changed masses151. To be clear, MM force-fields
generated during the parameterization process that use mass-dependent target
data are designed to capture the intra-molecular motions driven by the BO surface
not the BO surface itself and as such we would expect that the bonded force-field
parameters derived from mass-dependent dynamics (normal modes and massweighted internal coordinate distortions) are themselves implicitly massdependent.
For the re-parameterization approach, CHARMM-compatible150 force-field
parameters for deuterated THF (D8THF) were obtained using Gaussian09 152 and
an in-house modified Force-field Toolkit (FFTK)150 which updates the standard
Gaussian input files for D8THF with the keyword iso=2 after H atoms. In the bond
optimization step of FFTK, Gaussian09 includes the isotope effect by calculating
the Hessian matrix by converting force constants to mass-weighted Cartesian
coordinates (MWC)149 and then calculating mass-dependent internal coordinates
(ICs). FFTK uses these mass-dependent ICs to generate target distortion energies
for use in parameter fitting. Parameterizing all bonds, angles, and dihedrals was
required because local isotopic effects not only modify the H/D-C bonds but can
also propagate throughout the entire molecule, resulting in changes to all angles
and dihedrals that involve any carbons bound to an isotopic substitution site 123, 153.
All the partial charges and Lennard Jones parameters were kept the same as the
CHARMM32 ether force-field147. To check whether the use of FFTK alone does
not result in parameters for THF that would result in the loss of the THF-water
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miscibility gap, we also re-parametrized the fully hydrogenated THF (denoted as
THFK in the remainder of the text). The bonded parameters from FFTK for
hydrogenated THF (THFK) and deuterated THF (D8THF) generated using FFTK
are provided in Tables 2.1-2.4 and SI Tables 2.5-2.8, respectively. The
parameters generated from FFTK are in CHARMM/NAMD format and were
converted to GROMACS format using the Topotools154 (Topogromacs155) plugin in
VMD156.

Simulation details
Two stages of simulations were performed in this study. The first of these was
aimed at providing an initial comparison (and validation check) of the mass
substitution method and the re-parameterization approach in modeling the
behavior of bulk D8THF and the second stage examined the impact of the two
approaches in the representation of water-D8THF binary systems. For the first
stage, a single bulk environment was used throughout while in the second stage
two separate sets of simulations were performed: 1) large-scale simulations of
(D8)THF-water mixing behavior within the THF-water miscibility gap temperature
regime and 2) small-scale simulations of well-mixed (D8)THF (at multiple
temperatures) to obtain well-sampled detailed descriptions of D8THF-water
interactions.
For the first stage of simulations (i.e., the bulk organic solvent case), small boxes
of 1,000 molecules of the D8THF, HTHF, THF, and THFK systems were prepared
using the gromacs gmx solvate command. Following box construction an energy
minimization was performed using the steepest descent algorithm for a maximum
of 100,000 steps and with a stopping tolerance of 1 kJ/mol/nm. Post-minimization,
the systems were subjected to two rounds of NPT MD equilibration for 10 ns, each
with timestep of 0.2 fs. In the first of the NPT equilibration simulations, the pressure
and temperature were controlled using the Berendsen 157 thermostat and barostat
and the second NPT equilibration simulation the V-Rescale thermostat158 and the
Parrinello-Rahman159 barostat were used. Production simulations (of length ~0.8
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ns with timestep of 0.05 fs) of the systems were performed using the Berendsen
algorithm157 thermostat and barostat. These simulations were used to calculate IRspectra, the density and diffusion constants (see analysis details).
For the large-scale simulations, large cubic boxes (side length ~16.5 nm) were
constructed of THF: water, HTHF:water, THFK:water and D8THF: water with a
mass ratio of 0.4 (total system size: ~473,540 atoms). In the initial configuration,
the water and isotopologes were completely phase-separated, as shown in Fig.
2.1. Energy minimization was performed using the steepest descent algorithm for
a maximum of 10,000 steps and with a stopping tolerance of 100 kJ/mol/nm.
Following the minimization, a short (1 ns) equilibration simulation in the NPT
ensemble was performed, followed by an NPT production simulation for 400 ns
with a timestep of 1 fs at 90°C.
For the detailed small-scale D8THF-water system, MD simulations at five different
temperatures (30°C, 75°C, 105°C, 130°C and 165°C) with 1250 TIP3P (water)
molecules and 125 THF molecules (mass ratio of THF to TIP3P of ~0.4 m/m or
mole fraction of 0.09 THF/water) were performed. The number of atoms was
chosen to coincide with prior computational work 140. These simulations were
performed for all four systems; THF, HTHF, D8THF, and THFK. Each temperature
was simulated with three independent runs, with an integration step of 1fs, for 150
ns. Frames were saved for analysis every 10ps.
All THF-Water systems were prepared using a standard three-step process:
energy minimization (to remove potential clashes during model construction),
followed by short pressure relaxation simulations, and finally canonical (NVT)
ensemble production simulations. Energy minimization was performed using the
steepest-descent algorithm, as implemented in the GROMACS 2016 software
package144,

145

with a convergence criterion of 100 kJ/ (mol·nm). Relaxation

simulations in the NPT ensemble were performed for 2 ns at each temperature
with the pressure fixed to 1 bar with the Berendsen barostat 157. Following the NPT
relaxation, the volume was taken to be fixed, and the V-Rescale thermostat158 was
used to control the temperature, and the simulation protocol (as noted above) was
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used to generate production runs for analyses. In both the pressure relaxation and
production simulations, bond constraints were not used.

Analysis details
For the initial comparison of two approaches to modeling isotope substitution (i.e.,
the naïve substitution and re-parameterization approaches), the average density,
self-diffusion coefficient, and IR spectra of THF and deuterated THF were
calculated. IR spectra were calculated from the autocorrelation function of the total
dipole moment of the simulation box, as shown in Proprotnik et al160.
The molecular behavior of the D8THF, HTHF, THFK, and THF−water systems was
characterized using a combination of calculated radial distribution functions
(RDFs), hydrogen-bond counts, and hydrogen-bond lifetimes. Additionally, the
RDFs were used to calculate coordination numbers and second virial coefficients
(pair interaction strengths)161. Each of these metrics was calculated for all
temperatures and all independent trajectories, with the average and standard error
of the mean reported. A comparison between THFK with THF, HTHF, and D 8THF
is provided as supplementary material accompanying this manuscript.
Coordination numbers were obtained by computing the site−site RDFs between
the THF oxygen and hydrogen atoms and the water atoms and then integrating
the resulting profiles up to the first minima. RDFs were obtained using the
GROMACS gmx rdf utility. Fig. 2.10 illustrates our pair selections, and table 2.9
provides integration cutoffs. The cutoffs correspond to the first minima in the sitesite RDF.
Hydrogen bond counts were calculated with the built-in gmx hbond utility in
GROMACS. Hydrogen bonds were taken to be within donor-acceptor distances of
0.32 nm with a cutoff angle of 20°. As a proxy for the strength 162-164, lifetimes were
computed from autocorrelation functions of each hydrogen bond, as described by
Van der Spoel et al162.
Diffusion constants were obtained by first calculating the velocity autocorrelation
function (using gmx velacc) and then integrating the function to obtain a diffusion
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constant (with the integration performed using the gmx analysis tool). The
functional form of this (Green-Kubo) relationship between the velocity
autocorrelation function and the diffusion constant is:
1 ∞
𝐷 = ∫ ⟨𝑣⃑(𝑡′)|𝑣⃑(𝑡′′)⟩ 𝑑𝑡
3 0
where ⟨𝑣⃑(𝑡′)|𝑣⃑(𝑡′′)⟩ is the velocity autocorrelation function, and D is the diffusion
constant. Standard errors were calculated by splitting the trajectories into three
equal time windows and calculating the diffusion constants in each window.
The pair interaction strengths (D8THF-D8THF, HTHF-HTHF, THFK-THFK, and
THF- THF; D8THF-water, HTHF-water, THFK-water, and THF-water; water−water)
were quantified using the second virial coefficient (B2). The virials were calculated
using the standard McMillan-Mayer formalism161, 165 :
∞

𝐵2 = −2π ∫ [𝑔(𝑟) − 1]𝑟 2 d𝑟
0

where r is the distance and g(r) is the radial pair distribution function.
Density profiles for all the four large systems (D 8THF, THF, HTHF, THFK) were
calculated by averaging over all the three dimensions using the GROMACS gmx
density utility. The GROMACS gmx energy utility was used to calculate the mean
reported throughout the text, and the error estimate reported is for the standard
error of the mean (SEM).

2.4 Results
Parameter validation studies
A) Density
From the MD simulation of THF and THFK, the density was calculated to be 879.82
(+/- 0.5) kg/m3 and 881.84 (+/- 1.1) kg/m3 respectively, values somewhat lower
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than the experimental value166 of 889 kg/m3. The experimentally determined
value167, 168 of D8THF is much higher, at 985 kg/m3. Most of this increase arises
from the mass change, with the density of the simulated HTHF calculated as
975.47 (+/- 1.5) kg/m3. However, the average density of D8THF was found to be
980.33 (+/- 1.2) kg/m3, and thus the change in parameters for D 8THF leads to a
model more closely matching experiment.

B) Diffusion
The self-diffusion constant (D) of D8THF, HTHF, THF, and THFK was calculated
for all four systems. Although the absolute values of D are approximately 30%
lower than the experiment (diffusion constants are notoriously difficult to reproduce
quantitatively169), the effects of deuteration are correctly reproduced. The increase
in mass in HTHF (for which D=2.18 (+/- 0.0001) × 10-9 m2/s) slightly decreases D
relative to that of THF (DH=2.20 (+/- 0.0001) × 10-9 m2/s). The D value of THFK
(2.10 (+/- 0.00005) × 10-9 m2/s) is slightly lower than THF. Interestingly D 8THF
shows a further decrease in the value of D (DD=1.93 (+/- 0.0001) × 10-9 m2/s) as
compared to HTHF. This difference in the values of the diffusion constants (D)
between THF and D8THF calculated from MD simulations (0.27 m2/s) is consistent
with the difference (0.23 m2/s) in the experimentally determined values (THF 2.84
(+/-0.03) × 10-9 m2/s and D8THF 2.61 (+/-0.03) × 10-9 m2/s)170. Moreover, the ratio
(Dr-1=DH/DD) for D8THF calculated from MD simulations (1.13 +/- 0.00007) is also
comparable to the experimental value (1.09 +/- 0.02))170 which corresponds to a
difference of ~3.5% from the experimental values, whereas for HTHF the ratio is
1.009 +/- 0.00007 which corresponds to a difference of ~11% from experimental
values.
C) Infrared Spectra
IR spectra calculated from the MD simulations of D8THF, HTHF, THF are
compared with experimental peak positions 171 in Fig. 2.2, and for THF and THFK
are compared separately in Fig S1. For THF, experimental peaks assigned to C-H
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stretch (2977 cm-1, 2861 cm-1) are blue-shifted for D8THF (2226 cm-1, 2133 cm-1)
and align well with theoretical peaks (THF: ~2913 cm-1, ~2870 cm-1; D8THF: ~2225
cm-1, ~2130 cm-1; HTHF: 2159 cm-1, 2131 cm-1; THFK: 2987 cm-1, 2910 cm-1). The
experimental ring stretch assignment (THF: 1177 cm -1; D8THF: 1162 cm -1) aligns
well with the corresponding theoretical peaks (THF: ~1120 cm -1; D8THF: ~1163
cm -1; HTHF: ~1179 cm -1; THFK: ~1189 cm -1). All these peak positions171 show
that D8THF is closer to experimental peaks than HTHF in this region.
The fingerprint region of IR spectra (~500 to 1000 cm -1) from MD simulations is
known to be noisy and to exhibit non-uniform shifting172, 173. The fingerprint region
calculated from MD simulations of existing THF force-field does not properly align
with the experimental peaks, and thus isotopic shifts in this region should not be
interpreted in detail.
Effect of THF deuteration on the THF-Water miscibility gap
In order to capture macroscopic properties and examine the temperaturedependent closed-loop miscibility gap, 2D-density profiles for the large systems
(~473540 atoms) were calculated and averaged over the axes (X, Y, and Z), as
shown in Fig. 2.3-2.6. The initial configuration of all these systems was a phaseseparated state (Fig 2.1). The 0-50 ns density profiles clearly show a separation
of water molecules for all the four systems. The profiles for the THF-water, HTHFwater, and THFK-water systems show only minor changes throughout the
simulations, as is seen in Fig. 2.15, 2.16 and 2.18, and remain phase-separated
over the entire simulation (as shown by the continued phase-separation in the 350400 ns density profile window). In the D8THF-water system, however, the density
profile at the end of the simulation (350-400 ns) differs when compared to the initial
configuration, and there is no-longer a phase separation. Fig. 2.17 demonstrates
that this mixing starts relatively early, after the first 50 ns. The mixing in the D 8THFwater system and phase separation in THF, HTHF, and THFK systems shown by
density profile plots further indicate that the new parameterization agrees with
experimental results112, 113.
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THF-water interaction studies
A) Pair Interaction Strengths (Second Virials)
The second virial coefficient/pair interaction strengths (B2), derived from center-ofmass to center-of-mass RDFs, were computed for each temperature and are
shown in Figs 2.7 and 2.19 (in this and the plots that follow THFK is plotted
separately for clarity). In most of the cases, no significant differences (within the
error bars) are observed between THF and HTHF. However, the plots also show
that B2 is more positive (repulsive) for HTHF-water, THF-water, and THFK-water
interactions than for D8THF-water interactions. Similarly, an increase in D8THFD8THF interaction virials is observed at all temperatures relative to the THF, HTHF,
and THFK systems. Interestingly, for all three systems, the D 8THF, HTHF, THF,
and THFK -water interaction virials follow a near parabolic trend with temperature:
D8THF-D8THF, HTHF-HTHF, THF- THF, and THFK-THFK and water-water virials
are concave and D8THF, HTHF, THF, and THFK -water virials convex.

B) Hydrogen Bonds
To further investigate the intermolecular effects reported in Fig 2.7, the number of
hydrogen bonds was calculated and is presented in Figs 2.8 and 2.20. For all three
systems, the number of hydrogen-bonds was observed to decrease with
increasing temperature.
Also, again for all three systems, no significant differences were found for waterwater hydrogen-bonding. However, at all five temperatures the normalized number
of HBs in the D8THF-water system is larger than in the HTHF-water, THF-water,
and the THFK-water systems.
As a proxy for the strengths of the HBs162-164, their lifetimes were calculated and
are presented in Fig 2.9 and 2.21. The D8THF, HTHF, THF, and THFK -water and
water-water HBs are longer-lived at lower temperatures than at higher
temperatures. Interestingly, there are no significant differences in the HB lifetimes
of THF, HTHF, THFK, and D8THF-water. The lack of changes in the HB lifetimes
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indicates that, although there is an observed increase in the number of HBs
between D8THF-water, the overall stability of these hydrogen bonds is not
substantially altered.

C) Coordination Numbers
To further quantify the effect of deuteration on the microscopic structure of the
(D8)THF-water mixtures coordination numbers were calculated. RDFs between
atoms of D8THF, HTHF, THF, THFK, and water were calculated (with the cutoffs
mentioned in table 2.9 and atom names in Fig. 2.10). The coordination numbers
as a function of temperature indicate that the D8THF atoms H1H4/H2H3 and O1
coordinate more with water atoms, OW, and HW, respectively at all temperatures
than do THF, HTHF and THFK, as shown in Figs. 2.13 and 2.22. Correspondingly,
the atoms of THF, HTHF, and THFK coordinate slightly more with themselves
compared to D8THF, as shown in Fig. 2.12 and 2.23. At the same time, the selfcoordination number of the water atoms (HW-HW, OW-HW, OW-OW) is slightly
lower for D8THF than for the HTHF, THF, and THFK systems, as seen in Fig. 2.11
and 2.24. No changes in coordination are observed between HTHF and THF with
itself or water at any temperature.

2.5 Discussion
The aims of this work were: 1) examine if a classical MM force-field derived from
distortion energies contained an implicit isotopic bias (which would limits its ability
to capture isotope substitution effects upon simple mass-substitution) and, if so,
whether a re-parameterization method could take advantage of this bias and be
used to generate new MM parameters which could be used to capture the impact
of isotopic substitution, and 2) to examine, in molecular detail, what drives the
isotope-dependent loss of the THF-water miscibility gap upon the complete
deuteration of THF. To achieve these aims, we performed classical MD simulation
and force-field parameterization calculations for completely deuterated THF.

33

With regards to our first aim, we clearly demonstrated that a simple mass
substitution method (the HTHF systems above) fails to quantitively reproduce
shifts in density, self-diffusion, IR-spectra. Further, the use of this naïve mass
substitution approach also fails to capture the mixing of D 8THF with water, in
contrast to what is found experimentally. From the failures of the HTHF
simulations, two conclusions are possible: 1) the MM force-field may have a bias
that limits the applicability of mass-substitution for the study of isotopologues or 2)
quantum effects neglected in the classical representation are non-negligible for the
study of perdeuterated THF. By considering the success of the re-parameterization
approach (i.e., the D8THF simulations) capturing bulk perdeuterated THF
properties and the loss of the THF-water miscibility gap upon isotopic substitution,
it is clear that the second possible conclusion can be ruled out, as the reparameterization approach would only work in the case where the force-field
parameterization method was to capture the “proper” implicit isotopic bias (mass
corrected Eckart-Sayvetz conditions) and that the dynamics of interest contained
negligible non-local nuclear quantum effects.
With our results showing that classical MM force-fields (at least those fit to features
that contain mass-dependencies) contain implicit isotopic biases and that it is
possible to use classical MD (with a properly re-parameterized force-field) to
capture the isotope dependent loss of the THF-water miscibility gap, we return to
the second aim of this work: understanding the molecular origins of macroscopic
isotope-dependent behavior – in this case, the loss of the THF-water miscibility
gap upon per-deuteration of THF. Our results indicate that consistent with demixing, at all temperatures, the pair interaction strength of D 8THF-D8THF is more
repulsive than THF-THF (THFK-THFK, and the HTHF-HTHF) and D8THF-water
interactions are more attractive than in the THF, THFK, and HTHF systems.
Additionally, comparing the number of hydrogen bonds between the three systems
(HTHF-water, D8THF-water, THFK-water, and THF-water) shows that there is no
change between HTHF and THF containing systems across all the five
temperatures; while a comparison between the THF- and D8THF-containing
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systems show an increase in the number of water-organic solvent (i.e., waterD8THF) hydrogen bonds upon isotope substitution. However, the lifetime of
hydrogen bonds remains unaffected between all three systems. When we combine
these results with a closer look at the site-site coordination behavior of THF (both
deuterated and protonated), we find that the atoms O1, H1H4, and H2H3 of D 8THF
have significantly higher coordination numbers with both water hydrogen
(HW1/HW2) and oxygen (OW) atoms compared to the corresponding atoms in
HTHF and THF. The increase in coordination indicates that the change in the
force-field parameters D8THF increases the solvent accessibility of the oxygen for
D8THF (compared to fully hydrogenated THF). This increased accessibility then
serves to increase the number of favorable co-solvent (D8THF-water) hydrogen
bonds and provides additional favorable co-solvent-water interactions. We
observe that in the presence of water molecules, there is a change in all the angles
that make the overall structure squeeze and make the oxygen more exposed (Fig.
2.25). Interestingly, the QM normal modes also show that D 8THF molecule has
normal modes which result in more exposed O atom and THF has a normal mode
that opposes the accessibility of oxygen (Fig. 2.26). These physical changes in the
structure of the D8THF are responsible for the disappearance of the miscibility gap.
Hence, it is here that we find the origin of the isotope effect, arising from minor
changes to the structure of THF upon deuteration that increases the solvent
exposure of the O1 atom, permitting D8THF to accept more hydrogen bonds.

2.6 Conclusion
In this work, we demonstrated that classical MD simulations, using the CHARMM
force-field, contain implicit isotopic biases. Further, we demonstrated that careful
re-parameterization of the force-field parameters to account for the “proper”
isotopic bias permit the construction of new force-field parameters for use in the
examination of the impact of isotopic substitutions using classical MD simulations
(in the absence of nuclear quantum effects). This success suggests that a similar
methodology may be implemented in MD simulation of other deuterated systems.
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The methodology presented here may be of importance in the study of small
deuterated molecules of growing importance as pharmaceuticals 174, 175, and also
serve as an aid in the interpretation of experiments such as NMR 176 and neutron
scattering177 where isotope substitution can be of critical importance.
In addition to demonstrating the potential of using classical MD simulations to
account for physical isotope effects, the present MD simulations provide detailed
molecular insights into the origin of the loss of the THF-water miscibility gap upon
the complete deuteration of THF. The results indicate that upon deuteration, the
intramolecular interactions within THF are modified so as to modify the structure
of the molecule and allow for an increase in the formation of THF-water hydrogen
bonds (Fig 2.8, Fig 2.13). These new inter-molecular interactions then
compensate for the overall reduction of favorable THF-water interactions upon
heating and prevent D8THF and water from phase separating, thus eliminating the
miscibility gap.
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2.7 Appendix

Figure 2.1 Initial configuration of MD simulation of the 16.5nm-side box (Red: THF ;
Blue: Water)

Ring stretch
Experimental peak position

Absorbance (A.U.)

D8THF
THF
C-H stretch

Wavenumbers (cm-1)
Figure 2.2: Infrared spectra of D8THF (green), HTHF (blue), THF (red) as
calculated by MD simulations (lines) and experiments (peaks)
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0-50 ns

350-400 ns

Averaged over X axis

0-50 ns

0-50 ns

350-400 ns

350-400 ns

Averaged over Y axis

Averaged over Z axis

Figure 2.3: Density profiles of THF for different time intervals at 90°C. The
top row is the density profiles averaged over X, Y and Z directions for first
50 ns and the bottom row is the density profiles averaged over X, Y and Z
directions for last 50 ns
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0-50 ns

350-400 ns

Averaged over X axis

0-50 ns

0-50 ns

350-400 ns

350-400 ns

Averaged over Y axis

Averaged over Z axis

Figure 2.4: Density profiles of HTHF for different time intervals at 90°C. The
top row is the density profiles averaged over X, Y and Z directions for first
50 ns and the bottom row is the density profiles averaged over X, Y and Z
directions for last 50 ns
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0-50 ns

350-400 ns

Averaged over X axis

0-50 ns

0-50 ns

350-400 ns

350-400 ns

Averaged over Y axis

Averaged over Z axis

Figure 2.5 Density profiles of D8THF for different time intervals at 90°C. The
top row is the density profiles averaged over X, Y and Z directions for first
50 ns and the bottom row is the density profiles averaged over X, Y and Z
directions for last 50 ns

40

0-50 ns

350-400 ns

Averaged over X axis

0-50 ns

0-50 ns

350-400 ns

350-400 ns

Averaged over Y axis

Averaged over Z axis

Figure 2.6 Density profiles of THFK for different time intervals at 90°C. The
top row is the density profiles averaged over X, Y and Z directions for first
50 ns and the bottom row is the density profiles averaged over X, Y and Z
directions for last 50 ns

a)

b)

c)

B2

THF
HTHF
D8THF

Figure 2.7 Individual components of the second virial coefficient: a) D 8THFD8THF, HTHF-HTHF, and THF- THF, b) D8THF, HTHF, and THF -water c) waterwater. The standard error of the mean (SEM) are shown as error bars, and
those not visible are at most the size of the symbol.
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b)

No. of HBs/No. of Water
molecules

a)

THF
HTHF
D8THF

T (°C)

Figure 2.8 Average number of hydrogen bonds normalized by the number of
water molecules: a) D8THF, HTHF, and THF -water; b) water-water. Error bars
show the standard error of the mean (SEM), and those not immediately
visible are at most the size of the symbol.

a)

HB lifetimes (ps)

b)

THF
HTHF
D8THF

T (°C)

Figure 2.9 Mean hydrogen bond lifetimes: a) D8THF, HTHF, and THF -water;
b) water-water. Error bars show the standard error of the mean (SEM), and
those not immediately visible are at most the size of the symbol.
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Coordination numbers

Figure 2.10 Visual representation of coordination sites

HW-HW

OW-HW

T (°C)

OW-OW

THF
HTHF
D8THF

Figure 2.11 Water-water coordination numbers. Error bars show the standard
error of the mean (SEM), and those not immediately visible are at most the
size of the symbol.
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Coordination numbers

H1H4-H1H4

H2H3-H2H3

O1-H1H4

T (°C)
O1-O1

O1-H2H3

THF
HTHF
D8THF

T (°C)

Figure 2.12 Coordination numbers between D8THF- D8THF, HTHF- HTHF, and
THF-THF. Error bars show the standard error of the mean (SEM), and those
not immediately visible are at most the size of the symbol.
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H1H4-OW

H1H4-HW

H2H3-HW

Coordination numbers

THF
HTHF
D8THF

T (°C)
O1-HW

H2H3-OW

O1-OW

T (°C)

Figure 2.13 Coordination numbers between D8THF, HTHF, and THF -water.
Error bars show the standard error of the mean (SEM), and those not
immediately visible are at most the size of the symbol.
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Experimental peak position

Ring stretch

THF

Absorbance (A.U.)

C-H stretch

Wavenumbers (cm-1)
Figure 2.14 Infrared spectra of THF and THFK as calculated by MD
simulations (lines) and experiments (peaks)
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Figure 2.15 Density of THF for different time interval of 50ns at 90°C.
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Figure 2.16 Density of HTHF for different time interval of 50ns at 90°C.
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Figure 2.17 Density of D8THF for different time interval of 50ns at 90°C.
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Figure 2.18 Density of THFK for different time interval of 50ns at 90°C.
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b)

a)

c)

B2

THF
HTHF
D8THF
THFK

Figure 2.19 Individual components of the second virial coefficient: a) D 8THFD8THF, HTHF-HTHF, THF- THF, and THFK-THFK b) D8THF, HTHF, THFK and
THF -water c) water-water. Error bars show the SEM, and those not visible
are at most the size of the symbol.

b)

No. of HBs/No. of Water
molecules

a)

THF
HTHF
D8THF
THFK

T (°C)
Figure 2.20 Average number of hydrogen bonds normalized by the number
of water molecules: a) D8THF, HTHF, THFK, and THF -water; b) water-water.
Error bars show the SEM, and those not immediately visible are at most the
size of the symbol.
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a)

HB lifetimes (ps)

b)

THF
HTHF
D8THF
THFK

T (°C)

Coordination numbers

Figure 2.21 Mean hydrogen bond lifetimes: a) D8THF, HTHF, THFK, and THF
-water; b) water-water. Error bars show the SEM, and those not immediately
visible are at most the size of the symbol.

HW-HW

OW-HW

T (°C)

OW-OW

THF
HTHF
D8THF
THFK

Figure 2.22 Co-ordination numbers between water-water. Error bars show
the SEM, and those not immediately visible are at most the size of the
symbol.
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Coordination numbers

H1H4-H1H4

H2H3-H2H3

O1-H1H4

T (°C)
O1-O1

O1-H2H3

THF
HTHF
D8THF
THFK

T (°C)

Figure 2.23 Co-ordination numbers between D8THF- D8THF, HTHF- HTHF,
THFK-THFK, and THF-THF. Error bars show the SEM, and those not
immediately visible are at most the size of the symbol.
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H1H4-HW

H1H4-OW

H2H3-HW

Coordination numbers

THF
HTHF
D8THF
THFK

H2H3-OW

T (°C)
O1-HW

O1-OW

T (°C)

Figure 2.24 Co-ordination numbers between D8THF, HTHF, THFK, and THF water. Error bars show the SEM, and those not immediately visible are at
most the size of the symbol.
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Figure 2.25 Probability distribution of angles for THF (red) and
D8THF(green) in presence of water molecules at 105 °C
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Figure 2.26 QM IR spectra (top) and corresponding QM normal modes for
THF and D8THF (bottom)
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Table 2.1 Bonded terms of new D8THF parameters
Atom type Atom type
OC305A

CC325B

Kb

b0

267.635

1.441

V(bond)=Kb(b-b0)

2

CC325B

CC325B

241.951

1.523

Kb: kcal/mole/Å

CC325B

HCA25A

344.015

1.094

b0: Å

2

Table 2.2 Angle term of new D8THF parameters
Atom
type

Atom type Atom type

Kθ

θ0

V(angle)=Kθ (θ - θ0)

2

OC305A

CC325B

HCA25A

62.999

108.462

OC305A

CC325B

CC325B

141.069

106.72

Kθ: kcal/mole/rad

CC325B

CC325B

HCA25A

44.901

110.984

CC325B

CC325B

CC325B

108.129

100.701

θ0: degrees

CC325B

OC305A

CC325B

32.544

110.792

HCA25A

CC325B

HCA25A

24.863

107.157
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2

Table 2.3 Dihedral term for new D8THF parameters
Atom

Atom

Atom

Atom

type

type

type

type

Kχ

n

δ

HCA25A CC325B CC325B HCA25A

2.644

1

0

CC325B CC325B CC325B CC325B

2.597

1

180

CC325B OC305A CC325B CC325B

1.148

1

180

n: multiplicity

CC325B CC325B CC325B OC305A

2.992

1

180

delta: degrees

CC325B CC325B CC325B HCA25A

2.465

1

0

HCA25A CC325B CC325B OC305A

2.807

1

180

CC325B OC305A CC325B HCA25A

2.423

1

180

V(dihedral)=Kχ(1+cos(n(χ)-δ))
Kχ: kcal/mole

Table 2.4 Lennard-Jones potential term of new D8THF parameters
Atom

epsilon

Rmin/2

Ignored

eps1-4

Rmin/21-4

CC325B

-0.06

2.02

0

-0.01

1.9

HCA25A

-0.035

1.3

OC305A

-0.1

1.65

type
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Table 2.5 Bonded terms of new THFK parameters
Atom type Atom type
OC305A

CC325B

Kb

b0

262.599

1.438

V(bond)=Kb(b-b0)

2

CC325B

CC325B

241.762

1.526

Kb: kcal/mole/Å

CC325B

HCA25A

345.662

1.095

b0: Å

2

Table 2.6 Angle term of new THFK parameters
Atom type Atom type

Atom type

Kθ

θ0

OC305A

CC325B

HCA25A

58.594

108.351

OC305A

CC325B

CC325B

146.195

106.406

CC325B

CC325B

HCA25A

36.183

110.953

CC325B

CC325B

CC325B

109.996

101.417

CC325B

OC305A

CC325B

41.030

108.634

HCA25A

CC325B

HCA25A

42.288

107.785
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V(angle)=Kθ (θ - θ0)

2

Kθ: kcal/mole/rad
θ0: degrees

2

Table 2.7 Dihedral term for new THFK parameters
Atom

Atom

Atom

Atom

type

type

type

type

Kχ

n

δ

HCA25A CC325B CC325B HCA25A 2.999

1

0

CC325B CC325B CC325B CC325B 2.996

1

180

CC325B OC305A CC325B CC325B 1.773

1

180

CC325B CC325B CC325B OC305A 2.996

1

180

CC325B CC325B CC325B HCA25A 0.993

1

0

HCA25A CC325B CC325B OC305A 0.037

1

180

CC325B OC305A CC325B HCA25A 3.000

1

180

V(dihedral)=Kχ(1+cos(n(χ)-δ))
Kχ: kcal/mole
n: multiplicity
delta: degrees

Table 2.8 Lennard-Jones potential term of new THFK parameters
Atom

epsilon

Rmin/2

Ignored

eps1-4

Rmin/21-4

CC325B

-0.06

2.02

0

-0.01

1.9

HCA25A

-0.035

1.3

OC305A

-0.1

1.65

type
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Table 2.9 Cutoffs for Coordination Number Calculations
(Cutoff = location of first minima in corresponding site−site RDFs)
Site 1

Site 2

Cut off (nm)

THF-O1

water-OW

0.34

THF-O1

water-HW

0.25

THF-O1

THF-O1

0.53

THF-O1

THF-H1H4

0.38

THF-O1

THF-H2H3

0.36

THF-H1H4

water-OW

0.37

THF-H1H4

water-HW

0.41

THF-H1H4

THF-H1H4

0.31

THF-H1H4

THF-H2H3

0.32

THF-H2H3

water-OW

0.37

THF-H2H3

water-HW

0.51

THF-H2H3

THF-H2H3

0.35

water-OW

water-OW

0.37

water-OW

water-HW

0.25

water-HW

water-HW

0.31
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3 STUDYING GLOBAL AND LOCAL MOTION/DYNAMICS OF
BACTERIAL PROTEINS
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3.1 Promiscuous binding of bacterial Siglec-like adhesin Hsa to
human and animal sialoglycan receptors
3.1.1 Abstract
Sialoglycan binding proteins such as adhesin proteins play a crucial role in many
biological activities. Multiple adhesin proteins exist with distinct affinities towards
different sialoglycans. Adhesin proteins like GspB and SrpA exhibit selective
binding or preferential binding towards Neu5Ac-Gal or Neu5Gc-Gal, respectively,
whereas adhesin protein Hsa exhibits promiscuity and binds both these sugars
equally. However, the mechanisms behind the selectivity and binding of different
adhesin proteins to the respective sialoglycans are still not very well understood.
To explore this further, we first determined the co-crystal structures of Neu5Ac-Gal
and Neu5Gc-Gal disaccharides, respectively, with the sialoglycan binding region
of the unselective adhesin protein Hsa (HsaBR) from S. gordonii strain Challis. We
then used molecular dynamics (MD) simulations to study the promiscuity in the
binding of HsaBR to both Neu5Ac-Gal and Neu5Gc-Gal disaccharides. We further
contrasted the binding mechanism in HsaBR with that observed in selective
adhesins mentioned above. Here, we report a potential mechanism behind the
promiscuity or decreased selectivity of HsaBR when compared to other selective
adhesin proteins GspB and SrpA.
3.1.2 Introduction
Sialic acid carrying glycans (sialoglycans), present on the surface of platelets, play
a crucial role in the pathogenesis of Streptococci viridians-associated infective
endocarditis (IE), a life-threatening cardiovascular infection178-180. This group of
Streptococci can bind to sialoglycans using adhesin proteins present on their cell
surfaces to initiate adherence181-183. Sialic acid (Sia) collectively refers to a broad
range of neuraminic acid derivatives. Although over 50 distinct forms of Sia are
found in nature, N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid
(Neu5Gc) are most commonly observed184. Unlike most animals, human cells have
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lost the ability to synthesize Neu5Gc and hence only contain Neu5Ac 184. The only
difference between the structures of Neu5Gc and Neu5Ac is the presence of an
extra hydroxyl group in Neu5Gc at the C11 position as shown in Fig. 3.1. It has
been proposed that the loss of Neu5Gc biosynthesis confers an evolutionary
advantage in humans by allowing resistance to ancient forms of the malaria
parasite that used Neu5Gc as a receptor 185, whereas on the contrary, V. cholerae
has evolved into a human-specific pathogen partly by adapting to this evolutionary
loss of Neu5Gc186. Sialoglycans and their binding proteins appear to play important
roles in many biological recognition mechanisms and diseases 187-189. Interestingly,
their binding properties suggest potential applications as specific probes for
investigating the role of cell surface carbohydrates during the development and
malignant transformation of cancer cells 190-193. A recent paper has also reported
that Neu5Ac has a high affinity towards the SARS-CoV-2 spike glycoprotein194.
Although these studies provide details about the different sialoglycan binding
proteins, the respective binding mechanisms are still not well understood.
Similar to most sialoglycan-binding proteins, the streptococcal adhesin proteins
are Sia-recognizing immunoglobulin superfamily lectin (Siglec) like and interact
with a range of sialoglycans with different selectivities, as has been characterized
by a glycan array analysis195. Some Siglec-like adhesins, such as GspB from
Streptococcus gordonii strain M99, bind selectively to Neu5Ac-containing
sialoglycans195. In contrast, Siglec-like adhesins such as SrpA from S. sanguinis
strain SK36 can bind to both Neu5Ac and Neu5Gc but bind to Neu5Gc-containing
sialoglycans with a higher affinity than those containing

Neu5Ac

196

. Other

adhesins, such as Hsa from S. gordonii strain Challis, have dual specificity and
bind with similar affinities to both Neu5Ac and Neu5Gc 195. The mechanism or
reasoning behind the specificities of these adhesins is still not well understood.
Previous studies on Neu5Gc bound to the binding region (BR) of SrpA have
suggested that the formation of a specific hydrogen bond with the extra hydroxyl
on Neu5Gc (C11 position of Sia, Fig. 3.1) potentially allows SrpABR to bind
preferentially to Neu5Gc197, thus concluding that specific contacts to the C11
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hydroxyl on Neu5Gc dictate human versus animal Sia selectivity in members of
this family of bacterial adhesins. However, this mechanism fails to explain the
promiscuity observed in the case of Hsa- like adhesin proteins, which bind both
Neu5Gc and Neu5Ac -containing sialoglycans with equivalent affinities195. Prior
structural studies on the Neu5Ac/Neu5Gc promiscuous S. gordonii HsaBR have
identified that binding to a Neu5Ac-based trisaccharide (sialyl T antigen (sTa))
involves a conformational selection mechanism198 in which the EF loop in the
binding site of Hsa changes its orientation to a “closed” state to form a hydrogen
bond198. Thus, one compelling hypothesis for the observed equivalent binding
affinities in Hsa for Neu5Ac/Neu5Gc is that distinct conformational states
accompany the binding of Neu5Ac- and Neu5Gc-based sialoglycans that promote
different contacts to the C11 position, similar to what has been observed for sTa.
The current study thus aims to examine in detail how an adhesin protein such as
Hsa can exhibit dual specificity for both Neu5Ac and Neu5Gc. To this end, we first
determined

the

co-crystal

structures

of

Neu5Ac-Gal

and

Neu5Gc-Gal

disaccharides, respectively, with the sialoglycan binding region of the adhesin Hsa
(HsaBR) from S. gordonii strain Challis (Fig. 3.2b). We found that the overall
structures of HsaBR bound to each sialoglycan were very similar, with an RMSD of
~1Å over C⍺ atoms. Interestingly, we observed that in the crystal structures HsaBR
was bound to Neu5Ac-Gal and Neu5Gc-Gal with different loop conformations- in
case of Neu5Gc-Gal the EF loop was in the “closed” state but in the Neu5Ac-Gal,
it was in the “open” state, which contradicted a previous HsaBR study with sTa
(Neu5Ac containing trisaccharide). However, corroborating the previous study with
sTa, analyses using molecular dynamics (MD) simulations showed that this
conformational difference between the two HsaBR crystal structures was a
crystallization artifact and that both disaccharides bound to the closed
conformation of the adhesin protein. Furthermore, using MD simulation of both
these crystal structures, we uncovered a potential mechanism behind the binding
promiscuity in Hsa. To provide further insights behind the comparatively higher
fidelity binding in more specific adhesin proteins, we performed in silico modeling
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and MD simulations on GspBBR (with non-native ligand Neu5Gc) and SrpABR (with
preferential ligand Neu5Gc) adhesin proteins that do not bind both sialic acid forms
with the same affinity.
3.1.3 Methods
System preparation and molecular dynamics simulation
The experimental work in this chapter was done by Dr. Tina Iverson’s group in
Vanderbilt University and Dr. Barbara Bensing’s group at University of California,
SF. Crystal structures of the binding region of adhesin proteins: Hsa BR with
Neu5Ac-Gal and Neu5Gc-Gal explained above were used. Molecular dynamics
(MD) simulations were performed on the proteins and glycan ligands using
Amber14 ff14SB and Glycam06199 parameters, respectively. The protein-glycan
bound system was hydrated by water model TIP3P 200 in an octahedral box of 10
Å around the protein in each direction. First, the protein was held fixed with a force
constant of 500 kcal mol -1 Å-2 while the system was energy minimized with 500
steps of steepest descent followed by 500 steps with the conjugate gradient
method. In a second minimization step, the restraints on the protein were removed,
and 1000 steps of steepest descent minimization was performed, followed by 1500
steps of conjugate gradient. The system was heated to 300 K while holding the
protein fixed with a force constant of 10 kcal mol -1 Å-2 for 1000 steps. Then, the
restraints were removed, and 1000 MD steps were performed. The SHAKE
algorithm201 was used to constrain all bonds involving hydrogen in the simulations.
MD production runs were performed at 300 K using the NPT ensemble and a 2 fs
time step with nonbonded cutoff of 10 Å. Temperature was fixed with the Langevin
dynamics thermostat202 and the pressure was fixed with Monte Carlo barostat 203.
Three independent runs were performed for each simulation. All the analyses were
performed using Pytraj python package204.
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3.1.4 Results and Discussion
Crystal structure comparison of HsaBR with Neu5Ac-Gal and Neu5Gc-Gal
The X-ray crystal structures of HsaBR with Neu5Ac-Gal and Neu5Gc-Gal
(residues 245–449 of the full-length protein) were determined to 1.5 Å resolution
using de novo phasing calculated from single-wavelength anomalous diffraction of
an osmium derivative. Each HsaBR protomer folds into two domains (Siglec and
Unique) (Fig. 3.2b). Siglec is the sialoglycan binding domain, and the function of
the Unique domain is still not well understood 205. The HsaBR co-crystals with
Neu5Gc-Gal and Neu5Ac-Gal contain 280 and 295 water molecules, respectively
and bound calcium (Ca2+) and sodium (Na+) ions. The calcium (Ca2+) and sodium
(Na+) ions were bound at the same place, as has been previously observed in the
apo state crystal structure (PDB 6EFC)198. The overall backbone structure of the
holo form with Neu5Ac-Gal and Neu5Gc-Gal bound was found to be very close to
the apo form (PDB 6EFC)

198

with the root mean square deviation (RMSD) of C⍺

atoms being 0.34 Å and 1.12 Å, respectively. To identify the differences between
the two bound structures, the crystal structures were superimposed. The overall
structures were very similar, with a root mean square deviation (RMSD) over the
C⍺ atoms of only 1.06 Å. Furthermore, we plotted the B-factors from both the
crystal structures to identify the flexibility of protein residues (Fig. 3.2a). The
flexibility of the C⍺ atoms of both the proteins was also very similar. The only
significant difference between the systems was in the EF loop (330-336) region.
This loop is particularly interesting because our previous molecular dynamics (MD)
simulation studies of the apo form of Hsa BR have shown that the EF loop can
sample two states: “open” and “closed”, and that the Neu5Ac containing the sialyl
T antigen (sTa) structure binds in the “closed” state (Fig. 3.9)198. In the case of
Neu5Gc-Gal, we observed that the carbonyl-O atom of Lys 335 (present in the EF
loop) forms a hydrogen bond with the hydroxyl group (O4) of Neu5Gc-Gal and EF
loop was crystallized in a “closed” state, similar to that seen in the sTa bound
crystal structure198 and in MD studies198. In the case of Neu5Ac-Gal, no such
interaction between Neu5Ac-Gal and Lys 335 was observed, and the protein EF
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loop was crystallized in an “open” state. These findings suggested that although
disaccharide (Neu5Ac-Gal) and trisaccharide (sTa) forms of Neu5Ac bind the
protein in the same pose in their respective crystal structures, Neu5Ac forms no
interaction with the Lys 335 in the disaccharide form (Neu5Ac-Gal) and is
crystallized in an “open” state, whereas it is crystallized in a “closed” state in
trisaccharide form (Fig. 3.9). Apart from the above, both the disaccharide
molecules (Neu5Ac-Gal and Neu5Gc-Gal) aligned perfectly on top of each other
and formed similar interactions in the binding pocket of the protein (Fig. 3.2b, 3.8).
Moreover, both Neu5Ac and Neu5Gc groups formed four common hydrogen
bonds with the residues in the binding pocket (with Tyr 337, Thr 339, Arg 340, Tyr
341), and Neu5Gc formed an additional hydrogen bond with Lys 335, as
mentioned above. The C11-hydroxyl group (the additional hydroxyl group present
only in Neu5Gc), however, did not form any hydrogen bonds with the residues in
the binding pocket but is present in close proximity of residues Lys 335, Ser 336,
Tyr 337, Tyr 338 and hence could have some short-range electrostatic interactions
(Fig. 3.2b).

Molecular dynamics simulation of the two crystal structures
Since a crystal structure provides only a static structure of the protein, hence to
derive detailed spatial and temporal information including a picture of the
accessible conformational sub-states, we performed MD simulations on both the
sialoglycan bound crystal structures. We calculated the root mean square
fluctuation (RMSF) of the respective Siglec domains in both the structures to
estimate the flexibility of the protein over the course of the simulations. Similar to
the X-ray B-factors, the RMSFs showed that in case of the Neu5Ac-Gal bound
structure, the EF loop region (330-336) was more flexible than that in the Neu5GcGal bound structure (Fig. 3.3). Other parts of the protein, however, had very similar
fluctuations.
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To further characterize the EF loop flexibility we calculated the distance of the EF
loop (Lys 335 backbone carbonyl) to the hydroxyl group present in Neu5Ac
(labeled as O4) as shown in (Fig. 3.1) to measure the “open” and “closed” state
distributions, as that was the only difference between the crystalized structures
(Fig. 3.4a, 3.9). Surprisingly, in contrast to what was seen in the crystal structure,
during the course of the simulation Neu5Ac-Gal bound structure also changed from
“open” to “closed” state. The latter also formed a hydrogen bond with the Lys 335,
as was observed for the Neu5Gc- and sTa-bound structures (Fig. 3.4c). It was
seen that the EF loop Neu5Ac-Gal bound structure remained in the “closed” state
once the hydrogen bond between Neu5Ac-Gal and Lys 335 was formed. This
result suggests that the “open” state of the Neu5Ac-Gal bound structure observed
earlier could be a crystal packing effect or an artifact of crystallization. On the other
hand, similar to the observation in the initial Neu5Gc-Gal bound crystal structure,
the EF loop in Neu5Gc-Gal structure remained in the “closed” state throughout the
course of the simulation (Fig. 3.4b).
To further examine the flexibility of Neu5Gc-Gal and Neu5Ac-Gal, we calculated
the root mean square deviations (RMSD) of the heavy (non-hydrogen) atoms of
the two disaccharides. The resulting probability distributions showed that the peak
of RMSD was around 1-1.5 Å for both the disaccharides, suggesting that they are
very inflexible in both the cases such that they remain very close to the initial pose
observed in the crystal structure (Fig. 3.5). Additionally, in the case of Neu5AcGal, we observed smaller peaks around 2-2.5 Å, which likely happened before
Neu5Ac-O4 hydroxyl formed the hydrogen bond with Lys 335.
Apart from the relative flexibility of the structures, it was observed that during the
course of the simulation the C11-OH group of Neu5Gc was faced/pointed in a
direction away from the protein and was completely solvent-exposed (44 (± 3.6) %
of 300 ns) (no protein atoms were found within 3 Å of C11-OH atoms). Interestingly,
this observation did not agree with a previous study on another Neu5Gc binding
protein, SrpA196, where it was suggested that a specific hydrogen bonding
interaction between the C11-OH group and a tyrosine residue of the protein (SrpA)
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is critical for binding to Neu5Gc196. In our study, in the case of HsaBR, the extra
C11-OH group in Neu5Gc did not have a bonding interaction with the protein,
making the overall sialoglycan-protein interaction similar to that with Neu5Ac. This
suggests that the extra C11-OH group in Neu5Gc does not play a role in binding
to HsaBR, which could potentially be a reason behind the adhesin protein’s
promiscuous equivalent affinity binding to both the sialoglycans.

Comparison with other adhesin protein: SrpA and GspB
Hence, to get further insights on this binding mechanism of Neu5Ac-Gal and
Neu5Gc-Gal in the adhesin binding pocket, we explored the crystal structure (PDB
5EQ3)196 of another adhesin protein SrpABR (from S. sanguinis strain SK36) that
binds preferentially to Neu5Gc.
To further explore if the lack of C11-OH interaction in Neu5Gc could be driving
Hsa’s promiscuous binding to both the sialoglycans, we performed MD simulations
on other selective adhesin proteins to contrast and identify potential differences in
the sialoglycan binding mechanisms compared to Hsa. We first explored the bound
structure of adhesin protein SrpABR (PDB 5EQ3196, from S. sanguinis strain SK36)
that preferentially binds to Neu5Gc over Neu5Ac. As with HsaBR bound with
Neu5Gc-Gal, the C11-hydroxyl group of Neu5Gc is in close proximity to the
residues in the binding pocket of SrpABR: Arg 342, Ala 341, Gln 344 and Phe 345.
However, unlike HsaBR, Tyr 368 in SrpABR formed a hydrogen bond with the C11hydroxyl group of Neu5Gc. Notably, it was observed that in HsaBR, a tyrosine
residue corresponding to that seen in SrpABR was missing, thus precluding the
formation of a “selective/selectivity defining” hydrogen bond with the C11-hydroxyl
group of Neu5Gc in HsaBR. This further explains the observation that C11 hydroxyl
group is facing outward (away from the protein) in Hsa BR crystal structure and in
MD simulations, and instead forms interactions with water molecules (Fig. 3.7b).
In line with this, in the SrpABR crystal structure (PDB 5EQ3) the C11-hydroxyl group
of Neu5Gc faces inward (towards the protein) 196 (Fig. 3.7a) as a more favorable
interaction with the Tyr residue is available. Additionally, MD simulations of SrpABR
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with Neu5Gc-Gal showed that, similar to HsaBR, the C11-hydroxyl group of
Neu5Gc did exhibit intermittent interactions with the solvent but primarily
maintained atleast a single hydrogen bond with Tyr 368 in SrpABR (Fig 3.6). This
further confirmed that the hydrogen bond with Tyr 368 in SrpABR, is the reason
behind its preferential binding to Neu5Gc, as has been reported before196.
The above observations explain/confirm the mechanism behind the selective
binding of certain adhesin proteins to Neu5Gc but fail to elucidate the mechanism
behind the selective binding of Neu5Ac by other adhesin proteins. To explore this
further, we compared the crystal structures and performed MD simulations on the
adhesin protein GspBBR (from Streptococcus gordonii strain M99) which selectively
binds Neu5Ac. Hence, a good comparison would be that of GspBBR structures with
Neu5Ac and Neu5Gc. However, the crystal structure of GspBBR bound to Neu5Gc
does not exist. Therefore, we modified in-silico Neu5Ac to Neu5Gc in the existing
structure of GspBBR bound to sTa (PDB 5IUC)206. Following this we performed
short simulations of this model. We found that the C11-hydroxyl group of Neu5Gc
was surrounded by residues (Thr 478, Ile 479, Gly 480, Asp 481, Tyr 482 and Arg
585) when placed similar to the OH group in Hsa BR and SrpABR crystal structures
but it is also in close proximity to a more hydrophobic region (Ile 479 and Thr 478)
compared to HsaBR and SrpABR (Fig. 3.7 a,b). These hydrophobic residues would
preferentially interact with hydrophobic C-11 (methyl) of Neu5Ac more than
hydrophilic C-11 hydroxyl of Neu5Gc. The overall surface representation of the
HsaBR and SrpABR was observed to be slightly less hydrophobic and hence more
accommodating to the hydrophilic hydroxyl group when compared to GspB BR (Fig.
3.7c).
Unlike SrpABR and HsaBR, during the course of the simulation GspBBR forms a
hydrogen bond with Arg 585 in the Unique domain. Although we were not able to
capture the unbinding of Neu5Gc from GspBBR during the course of the simulation,
we hypothesize that these extra hydrophobic residues and the hydrogen bond with
Arg 585 potentially leads to the unbinding of Neu5Gc, due to the interdomain
motion (between Siglec and Unique domains).
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3.1.5 Conclusion
Here, we report crystal structures of HsaBR bound to Neu5Ac-Gal and Neu5Gc-Gal
combined with extensive MD simulations. The results provide insights into the
mechanism behind the dual specificity of HsaBR adhesin towards the commonly
found sialic acids. We found that HsaBR can bind to Neu5Gc even in the absence
of a specific tyrosine residue (present in SrpABR), which has previously been
considered essential for binding Neu5Gc196. In line with this, we also observed that
unlike SrpABR, the additional C11-OH group of Neu5Gc does not form a direct
interaction with the residues in HsaBR because the selectivity defining Tyr residue
is not present HsaBR, and this prevents its preferential binding to Neu5Gc. We also
find that HsaBR does not have the hydrophobic residues (Ile 479 and Thr 478) as
in GspBBR which potentially make GspBBR selective towards Neu5Ac. Taken
together, these results show that Hsa lacks the features present in the selective
adhesins (GspBBR and SrpABR) and this forms the basis behind the observed dual
specificity/binding promiscuity of Hsa towards both the sialic acids. Moreover, this
study also provides insight into the selectivity of GspB BR and SrpABR for Neu5Ac
and Neu5Gc, respectively.
Lastly, since we were not able to observe the unbinding of Neu5Gc in the GspBBR
simulations and because our simulation was performed starting with a Neu5Gc
bound structure, we hypothesize that the C11-OH group of Neu5Gc possibly
affects the protein’s interaction prior to binding (i.e. in the process of binding).
Nevertheless, we acknowledge that there is a possibility that the MD force-field
parameters of sugar molecules may not have sampled some interactions
accurately. Thus, further work needs to be done to test these hypotheses but are
orthogonal to this paper.
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3.1.6 Appendix

Figure 3.1 Two-dimensional structure of disaccharide: N-glycolylneuraminic
acid (Neu5Gc)-Galactose (Gal), showing the important atom names and the
additional C11- hydroxyl group, substitution (with hydrogen) of which makes
it N-acetylneuraminic acid (Neu5Ac).

Figure 3.2 a) B-factor from the crystal structures of Hsa BR bound to Neu5AcGal (in blue) and Neu5Gc-Gal (in red); b) the superimposition of the overall
two crystal structures showing two domains (Siglec and Unique), and
focused view of the binding pocket showing side-chain residues and the
hydrogen bonds between backbone carbonyl-O atom in Lys 335 of the EF
loop and Neu5Ac-Gal’s hydroxyl-O (O4) group in white dotted line.
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Figure 3.3 Root mean square fluctuation (RMSF) of the Siglec domain of
HsaBR bound to Neu5Ac-Gal (in blue) and Neu5Gc-Gal (in red). The error
bars are standard error of mean (SEM) over three independent simulations.

Figure 3.4 (a) Superimposition of the crystal structures of Hsa BR bound
Neu5Ac-Gal (in blue), Neu5Gc-Gal (in red), and MD snapshots (in white)
with distance (D) between Lys 335 backbone carbonyl and Neu5Ac-O4
atom shown with a black dotted line. Distance (D) over simulation time of
three independent runs of HsaBR bound to (b) Neu5Gc-Gal and (c) Neu5AcGal.
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Figure 3.5 Probability distribution of root mean square deviation (RMSD) of
disaccharide: Neu5Ac-Gal (a) and Neu5Gc-Gal (b) bound to HsaBR over
three independent simulation runs.

Figure 3.6 Number of hydrogen bonds between Tyr 368 in SrpABR and C11
hydroxyl group of Neu5Gc.
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Figure 3.7 Binding pocket of a) SrpABR; b) HsaBR; c) GspBBR adhesin
proteins. Top panel shows the lipophilicity surface view of the pocket bound
to Neu5Gc (red stick); Bottom panel shows the key residues (white stick) in
the pockets of the corresponding proteins.
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Neu5Ac-Gal

Neu5Gc-Gal

Figure 3.8 Interaction map of Neu5Ac-Gal and Neu5Gc-Gal in Hsa

Figure 3.9 Open and closed conformation of Hsa loop bound to different
substrate.
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3.2 Precise orientation of bacterial adhesin is critical for host
adherence
3.2.1 Abstract
Proteins present on bacterial cell surfaces play a major role in facilitating their
adherence to the host cell. Previous work has reported that the cellular
environment, attachment surfaces, and the selectivity of these adhesin proteins
plays a role during surface adhesion. A protein’s orientation during binding is also
considered important for effective binding but such studies on adhesin proteins are
currently lacking. There is thus a need to characterize the role of orientation and
positioning of these proteins on the bacterial surfaces to understand their
significance in maximizing binding probability to the host cells. Here, we focus on
one such group of adhesin proteins, known as Serine Rich Repeat (SRR) adhesin
proteins, which are present on the surfaces of streptococci and staphylococci.
These bacteria are notorious for causing infective endocarditis, a potentially fatal
cardiovascular infection, and their adherence to the host platelets via adhesin
proteins is a critical step during pathogenesis. In our study, we used a combination
of biochemical and computational approaches to explore if the orientation of these
adhesin proteins is critical for binding to the host platelets and whether changes to
the orientation have an influence on the binding. Here, we report that the
orientation of adhesin proteins is crucial for binding and slight changes significantly
reduces binding affinity/ability. Additionally, our results suggest that although the
Unique domain in these SRR adhesin proteins does not affect its binding pocket,
it is essential for retaining the binding pocket orientation by maintaining the
required rigidity in the inter-domain region.
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3.2.2 Introduction
Proteins presented on the surfaces of cells are critical for interactions with the
environment surrounding them, including other cells207,

208

. This is especially

important for disease causing bacteria, who use many different mechanisms and
specialized cell-surface proteins to facilitate adherence to host cells208. These
attachments are often a prerequisite for colonization and constitute the first stage
of numerous microbial infections207. In most cases, bacterial adherence to a
eukaryotic cell or the tissue surface requires a receptor and a complimentary
ligand. The host receptors are usually some specific carbohydrate or peptide
residues presented on their cell surfaces. The bacterial ligands are typically
proteins, such as adhesin proteins, which are presented on the bacterial cell
surfaces and interact with the host cell receptors. These adherences can range
from being non-specific to extremely specific depending on the mode of action.
Non-specific adherence involves overall physicochemical properties of the
bacterial and host surfaces, such as charge and hydrophobicity; whereas specific
adherence involves many high-affinity interactions (similar to a lock and key model)
between the complementary receptor on the host cells and the adhesin proteins.
Although countless studies have shown the importance of bacterial adhesion in
numerous life-threatening diseases, the mechanism of these interactions is still not
well understood.
Previous studies have identified three main factors that influence bacterial
adhesion to cell surfaces - i) the liquid environment, ii) the attachment surface,
and iii) the bacterium itself209-212. The third factor is usually under the control of the
invading bacteria, and extensive work has been done on how bacteria have
evolved and adapted to increase the specificity and selectivity of their adhesin
proteins198, 205, 213. Apart from specificity, the orientation of the interacting partners
is also considered as a deciding factor for any successful binding214. Although
numerous studies have focused on the (sequences and) structures of these
surface proteins, there is still limited information about the precise orientation and
positioning of these proteins on the bacterial surfaces and their role in facilitating
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binding. This is thus a critical question because bacterial adhesin proteins ipso
facto evolved to maximize their binding probability to the host receptors.
Hence, to elucidate the role of orientation and positioning of surface proteins on
the bacterial surfaces, here we took the case of serine-rich repeat (SRR) adhesin
glycoproteins which bind to small carbohydrate molecules present on the human
platelets179. These adhesin proteins form fibril-like protrusions and are present on
the surfaces of streptococci and staphylococci205,

215-217

. These bacteria are

opportunistic pathogens implicated in multiple human diseases, including a fatal
cardiac infection called the Infective endocarditis (IE) 178, 218. In IE, the attachment
of the bacterial adhesin proteins to host platelets has been shown to be critical for
disease onset178, 218, and thus is also a target for disease intervention. Broadly,
these adhesins have a conserved architecture with five linearly-arranged modules:
1) N-terminal signal sequence; 2) short serine-rich repeat (SRR1); 3) host binding
region (BR) (contains two domains - Siglec and Unique domains); 4) second
serine-rich repeat (SRR2); and 5) C-terminal cell-wall anchoring motif181, 195, 196, 198,
205, 219

. As the name suggests, the BR region is important for binding to host

receptors and based on the size and domain organization of the adhesin protein,
it has previously been hypothesized that the extremely long SRR2 domain serves
to extend this BR through the bacterial capsular polysaccharide to mediate host
cell adhesion. In the BR, the Siglec domain has been well studied as it contains
the binding pocket, is responsible for interacting with the host and also known to
exhibit a high sequence diversity. The binding pocket of the Siglec domain and its
promiscuity in some SRR adhesins has been characterized in an earlier study.
Nevertheless, the role of the Unique domain in the BR has still been elusive.
However, we found that the adhesin proteins maintain a rigid interdomain (between
the respective Siglec and Unique domains) motion within the BR, and that this
interdomain torsion/angle is conserved for adhesins within the same clade of their
phylogenetic tree. Although, the exact structural role of the Unique domain is not
understood, it has been shown to not directly affect the binding pocket present in
the Siglec domain but could still be important for facilitating binding.
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We thus hypothesized that the interdomain rigidity allows the adhesin protein to
maintain a precise orientation on the surface of the bacteria which enables it to
form specific interactions with the sialoglycans present on the surfaces of host
platelets and that disrupting this rigidity/orientation would abolish their adherence
to the platelets (Fig 3.10). To this end, we performed molecular dynamics (MD)
simulations and biochemical assays to understand the evolutionary pressure
behind the conserved rigidity between the Siglec and Unique domains in SRR
adhesin BR and further explored if this is important for maintaining a particular
orientation of the binding pocket. The results not only suggest that orientation of
the binding pocket is important but also elucidate the role of the Unique domain in
the sugar-binding, dynamics, and structural integrity.
3.2.3 Methods
System preparation
Crystal structures of the sialoglycan binding proteins Hsa BR (PDB 6EFC)198,
GspBBR (PDB 6EFA)198, 10712BR (PDB 6EFF)198, SK150BR (PDB 6EFB)198, SrpABR
(PDB 5EQ2)196, and SK678BR (PDB 6EFI)198 were used in this study. Adhesin
protein GspB was chosen for further investigation and MD simulations of GspB
protein was performed under four systems: i) SigUnwild: all the residues of Siglec
and Unique domain present in the crystal structure; ii) SigUnmutALL: all residues in
the Unique domain that formed hydrogen bonds with Siglec domain were mutated
to alanine; iii) SigUnR585D: Arginine (R) in position 585 was mutated to Aspartic
acid (D); iv) SigUnR588D: Arginine (R) in position 588 was mutated to Aspartic acid
(D). Further details are present in Table 3.1 below.

Simulation details
For MD simulations, each system was solvated in a 10 Å octahedral box of TIP3P
220

water. The Amber16 ff14SB

221

force field was used for the protein. In the first

step of MD simulations, the backbone and side chains of the protein were restrained
using 500 kcal mol-1 Å-2 harmonic potentials while the system was energy minimized
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for 500 steps of steepest descent 222. This step was followed by 500 steps according
to the conjugate gradient method

58

. In a second minimization step, restraints on

the protein were removed and 1000 steps of steepest descent minimization were
performed followed by 1500 steps of conjugate gradient. The system was then
subjected to MD and heated to 300 K with the backbone and side chains of the
protein restrained using 10 kcal mol-1 Å-2 harmonic potentials for 1000 steps. The
restraints were then released, and 1000 MD steps were performed. The SHAKE223
algorithm was used to constrain all bonds involving hydrogen in the simulations.
MD runs were performed at 300 K in the NPT ensemble and a 2 fs time step.
Accelerated molecular dynamics (aMD) simulations72 were performed by using a
dual energy boost (i.e. Dihedral energy and Potential energy) with an acceleration
parameter (α) of 0.2. The average total potential energy and average dihedral
energy parameters for aMD were calculated from classical MD simulations. The
details about the duration of the simulations is mentioned in Table 3.1.

Analysis details
All analyses were performed on 1 µs simulations where 3 independent runs for
each system were considered. All the analyses were performed using cpptraj and
pytraj204 python modules.
The structure and the dynamics of the systems were characterized by Root Mean
Square Fluctuation (RMSF). Each of the metrics was calculated from the last 500
ns of simulation trajectory for each system.

Experimental assays
The experimental work in this chapter was done by Dr. Tina Iverson’s group in
Vanderbilt University and Dr. Barbara Bensing’s group at University of California,
SF.

82

Protein expression and purification
Cloning of the gspB BRs in pGEX-3X was performed as described previously in
ref

183

. Additional BRs were identified and then cloned similarly. Briefly, the

corresponding DNA coding regions, along with 5′ BamHI and 3′ EcoRI linkers, were
obtained as commercially synthesized products, or were amplified from
chromosomal DNA by PCR. After cloning in the pGEX-3X expression vector, the
wild-type and mutant BR coding sequences were confirmed by DNA sequence
analysis (Sequetech). Cultures of E. coli strain BL21 carrying the pGEX expression
plasmids were grown in LB with 50 µg/mL carbenicillin until an OD600 of ∼0.9, and
the expression of GST fusion proteins was induced by the addition of IPTG to a
final concentration of 1 mM. Cultures were incubated for 4 h at 24°C. Cells were
harvested by centrifugation and lysed by sonication, and the GST fusion proteins
were purified using glutathione-sepharose beads according to the manufacturer’s
instructions. The eluted proteins were exchanged into DPBS and stored at −80°C.
Binding of GST-BRs to platelet monolayers
To assess binding to platelets, fresh human platelets were washed, fixed and
immobilized in 96-well plates as described in ref224. All subsequent binding steps
were carried out at room temperature. To reduce non-specific adherence, the wells
were treated with 50 µL of 1× Blocking Reagent in DPBS for 1 h. The blocking
solution was replaced with 50 µL of purified GST-BRs, ranging from 0.16 to 2500
nM in 1× blocking solution. The plates were incubated for 1 h with vigorous rocking,
wells were rinsed three times with 100 µL DPBS, and 50 µL of a rabbit polyclonal
anti-GST diluted 1:500 in 1× blocking solution was added to each well. After 1 h,
wells were rinsed three times with 100 µL DPBS, and 50 µL of a peroxidase
conjugated anti-rabbit antibody (1:5000 dilution in DPBS) was added. After
incubation for 1 h, wells were rinsed three times with 100 µL DPBS, and 200 µL of
a solution of 0.4 mg mL−1 OPD was added. The absorbance at 450 nm was read
after ∼30 min, and the values of wells containing the GST-BRs were adjusted by
subtracting the average absorbance value of wells containing a GST control.
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Binding of biotinylated glycans to immobilized GST-BRs
Purified GST-BRs (500 nM in DPBS) were immobilized in 96-well plates, and the
binding of biotinylated glycans was assessed as described previously in ref

195

,

with minor modifications. In brief, multivalent biotinylated glycans were added to
wells at the indicated concentrations in DPBS containing 1× Blocking Reagent.
After 90 min at RT, wells were rinsed three times to remove the unbound glycans,
and bound glycans were detected with streptavidin-conjugated horse radish
peroxidase, along with a solution of 0.4 mg OPD per mL phosphate citrate buffer.
The absorbance at 450 nm was measured after ∼20 min.
3.2.4 Results and Discussion
Orientation of binding pocket are critical for platelet binding
The interdomain rigid body motion between the Siglec and Unique domains was
first analyzed to understand the potential importance of binding pocket orientation.
The interdomain torsion angles (Φ) between the Siglec and Unique domains were
calculated for the binding regions (BRs) of six different adhesin proteins (SrpA,
NCTC, Hsa, SK678, SK150 and GspB) as shown in Fig. 3.11. The results revealed
that the interdomain torsion angles (Φ) between the Siglec and Unique domains
for these adhesin proteins were grouped into two clusters. Interestingly, this
grouping was similar to what has been observed after phylogenetic analyses
where proteins from each group here were part of the same clade. Within each
group, it was seen that the Φ angles were similar and somewhat conserved- The
range of angles in GspB and SK150 adhesin BRs fell between 60º-120º (called the
GspB-like proteins), whereas the range of angles in Hsa, SK678, NCTC, and SrpA
adhesin BRs fell between 200º-260º (called the Hsa-like proteins) (Fig. 3.11).
These observations showed that interdomain rigidity is prevalent in all different
adhesin proteins and could be important adaptation in the adhesin proteins.
Additionally, the fact that the Φ angles are conserved within a group provide
impetus to the view that the orientation of the binding pocket and thus its
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maintenance potentially by the Unique domain could be significant for subsequent
binding.
Therefore, to further understand the importance of binding pocket orientation and
the role of Unique domain for sialoglycan binding in these proteins, we used GspB
as the test system and modeled two new systems- SigUnWild and SigUnmutALL
(SigUnmutALL was generated by alanine mutation of all the residues (R523A,
R559A, D562A, R585A, R588A) in the Unique domain that formed hydrogen bonds
with the residues in the Siglec domain so as to disrupt the interdomain rigidity). MD
simulations were then performed for 500ns on both these systems and the
interdomain angles and torsion between the Siglec and Unique domains were
calculated as shown in Fig. 3.12. We observed that as expected the 2-D histogram
of the wild type system (SigUnWild) sampled a tighter range of interdomain angles
that were centered around a minimum of 100°. On the other hand, the mutant
system (SigUnmutALL) had a comparatively much broader distribution of interdomain
angles and torsion to the point that the minimum was shifted to the left and
centered around 90º. (Fig. 3.12)
These observations suggested that the disruption of the hydrogen bonds between
the Unique and Siglec domains had made the mutant system very flexible and that
the Siglec domain or the binding pocket could no longer be restricted to a particular
orientation. To further focus on the key residues important for facilitating the
interdomain rigidity and thus maintaining the binding pocket orientation in the wild
type, we generated two more systems: SigUnR585D and SigUnR588D, by mutating
residues R585 and R588 from the residues identified in SigUnmutALL to aspartic acid
(D) and performed an enhanced sampling MD for 1µs. Both these residues were
chosen based on the location and the number of hydrogen bonds. We then
calculated the interdomain torsion and angles for both these systems for the last
500 ns of the simulation and compared it with an equivalent simulation of the wild
type (SigUnWild) (Fig. 3.13). For both the point mutation systems (SigUnR585D and
SigUnR588D), we observed a slight shift in the minima with a broader distribution of
angles when compared to wild type (SigUn wild). Although this change was less
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pronounced compared to SigUnmutALL, these single mutations were enough to
cause a shift in the minima (i.e. a change in binding pocket orientation) when
compared to wild type. Taken together, these observations confirmed that the
Unique domain is responsible for providing a stiffness to the Siglec domain so as
to maintain the binding pocket in a particular orientation, which is potentially critical
for binding the sialoglycans present on the platelet surfaces.
Based on the above, we hypothesized that a small change/relaxation in this
stiffness would modify the binding pocket orientation and prevent/inhibit bacterial
adhesion to platelets. Hence to test this hypothesis, we decided to construct the
two single point mutants (R585D and R588D) studied above and conduct an
ELISA to examine their binding to the platelets. As a positive control, we
constructed two other single mutants- L442K and Y485F, where L442 and Y485
are conserved residues in the binding pocket for GspB and are known to be critical
for sialoglycan binding.
We observed that both the experimental mutants (R585D and R588D) caused a
significant reduction in binding of the adhesin protein to the platelets when
compared to wild type (Fig 3.14). Interestingly, the reduction in the experimental
mutants was either similar or lower than that in the known binding mutants (Y485F
and L442K). These results confirmed that the orientation of the adhesin protein
binding pocket indeed plays an important role in their binding to the platelets
equivalent to that played by conserved residues in the binding pocket and that a
slight change in this orientation can significantly reduce the intended binding.

Mutation in the Unique domain has no global or local effect on the
structure and dynamics of Siglec domain
Sometimes mutations in one region of the protein can induce allosteric changes in
another region which can prevent binding, although this was unlikely because the
mutations were made in the Unique domain and were not close to the binding
pocket. Nevertheless, to further confirm that the mutations (R585D and R588D) in
the Unique domain reduced the binding as a result of change in domain orientation
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and not due to an allostery-like effect in the Siglec domain binding pocket, we
decided to explore the local effect of the mutation. To this end, we first calculated
the root mean square fluctuation (RMSF) of C-alpha atoms of the Siglec domain
for both the wild type and the mutant systems. Similar RMSF trends were observed
for the all these systems, suggesting that the fluctuations within the Siglec domain
were independent or not affected by the mutations in the Unique domain (Fig.
3.15).
To further experimentally validate these observations obtained from RMSF, we
conducted a fluorescence binding assay after immobilizing the wild type and
mutant proteins to explore the effect of these mutations on the binding of known
sialoglycan substrates irrespective of binding pocket orientation. Interestingly, we
observed that the binding to the known substrate (sTa) remained unaffected in the
case of R585D and R588D mutants after they were immobilized (their orientation
fixed) and that this signal was similar to that of wild type. On the other hand, both
the active site mutants (L442K and Y485F) still had significantly reduced binding
to the substrate when compared to wild type. These results confirmed that the point
mutations R585D and R588D in the Unique domain did not affect the structure of
the binding pocket and hence, the observed reduction in platelet binding was
driven by changes in the orientation of the binding pocket.
3.2.5 Conclusion
It is well established that the proteins present on the surface of the cells play a
major role in signaling, transport, movement and adhesion to other cells 207, 225. A
considerable amount of work has been done to understand the conservation of
structure, function, and binding selectivity of these surface proteins, especially in
bacteria that cause human infections207,

225

. Bacterial adhesion to human cells

using the bacterial adhesion proteins is a known cause of the pathogenies in many
diseases226. Although orientation of binding sites is known to be important for any
binding interaction, nothing is known about the importance of orientation of the
binding sites in these bacterial surface adhesin proteins. Here, we studied a group
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of proteins called the SRR adhesin proteins that enable bacterial binding to human
platelets during the pathogenesis of infective endocarditis178, 218, 227. We applied a
combination of computational and biochemical methodologies to show that indeed
the orientation of the adhesin binding pocket is critical for the binding the platelets
and a small shift in this binding site orientation is enough to significantly reduce
platelet binding. Overall, this study provides an improved understanding of the
binding mechanism of adhesin proteins and also identifies novel therapeutic
targets disease intervention.
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3.2.6 Appendix

Wild

Adhesin protein

Mutant

Platelet

Figure 3.10 Pictorial representation of the hypothesis showing that the
binding site orientation is critical for binding to the platelets. Note: The
picture is not to scale.
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GspB-like

Probability

Hsa-like

Angle Φ (°)
Figure 3.11 Probability distributions of the torsion angle (Φ) between the
Siglec and Unique domains of adhesin proteins GspB, SK150, Hsa,
NCTC10712, SK678, and SrpA (left) as calculated from MD simulations.
Crystal structures showing the Φ angle for both GspB-like and Hsa-like
proteins (right). The interdomain torsion angles in the corresponding crystal
structures are as follows: GspB: ~100°; SK150: ~100°; NCTC10712: ~228°;
Hsa: ~230°; SrpA: ~216°; SK678: ~240°.
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SigUnmutALL

SigUnWild

Figure 3.12 Two dimensional histogram of interdomain torsion () vs angle
() between Siglec and Unique for GspB systems: SigUnWild and SigUnmutALL
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SigUnWild

SigUnR585D

SigUnR588D

Figure 3.13 Two dimensional histogram of interdomain torsion () vs angle
() between Siglec and Unique for GspB systems: SigUnWild, SigUnR585D and
SigUnR588D
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Figure 3.14 Comparative binding of wild-type and mutant BRs of GspB to
immobilized platelets

)
RMSF (Å

SigUnWild
SigUnR585D
SigUnR588D

Residue number
Figure 3.15 Root mean square fluctuation (RMSF) of Siglec domain for
GspB systems: SigUnWild, SigUnR585D and SigUnR588D
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Figure 3.16 a) Binding of biotinylated sTa at different concentrations to
immobilized wild-type and mutants R585D, R588D, L442K, Y485F of GspB BR.
Binding is reported as the mean ± standard deviation, with n = 3.
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Table 3.1 System and simulation details of GspB

System

Residue number

Simulation time
Classical MD

Siglec & Unique

398-600

Accelerated
MD

500 ns

1 µs

500 ns

-

-

1 µs

-

1 µs

(SigUn)

398-600
Siglec & Unique
mutant
(SigUnmutALL)

(R523A, R559A,
D562A, R585A,
R588A)

Siglec & Unique
mutant
(SigUn R585D)
Siglec & Unique
mutant
(SigUn R588D)

398-600
(R585D)
398-600
(R588D)
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4 UNDERSTANDING THE EFFECT OF NON-NATIVE
CONDITIONS ON GLOBAL AND LOCAL DYNAMICS OF A
PROTEIN
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A version of this chapter was originally published by me:
Agarwal, Rupesh, Utsab R. Shrestha, Xiang-Qiang Chu, Loukas Petridis,
and Jeremy C. Smith. "Mesophilic pyrophosphatase function at high temperature:
a molecular dynamics simulation study." Biophysical Journal (2020).
In this work, I executed research, performed analysis, and wrote the paper. Dr.
Utsab Shrestha conceived the idea and made substantive contributions to the
manuscript’s content and Dr. Jeremy C. Smith, Dr. Loukas Petridis and Dr. XiangQiang Chu provided help in results discussion and edited the manuscript.

4.1 Abstract
The mesophilic inorganic pyrophosphatase from Escherichia coli (EcPPase)
retains function at 353 K, the physiological temperature of hyperthermophilic
Thermoccoccus

thioreducens,

whereas,

the

homolog

protein

from

the

hyperthermophilic organism (TtPPase) cannot function at room temperature. To
explain this asymmetric behavior, we examined structural and dynamical
properties of the two proteins using molecular dynamics simulations. The global
flexibility of TtPPase is significantly higher than its mesophilic homolog at all tested
temperature/pressure conditions. However, at 353 K, EcPPase reduces its
solvent-exposed surface area and increases subunit compaction while maintaining
flexibility in its catalytic pocket. In contrast, TtPPase lacks this adaptability and has
increased rigidity and reduced protein:water interactions in its catalytic pocket at
room temperature, providing a plausible explanation for its inactivity near room
temperature.

4.2 Introduction
The enzymatic activity of proteins from hyperthermophilic microorganisms thriving
in extreme conditions has been an active area of research for several decades228,
229

. These microbes have an optimal temperature range for their growth and

survival of about 80°C - 100°C

230

. In addition to extreme temperatures, these

microorganisms can also withstand high hydrostatic pressures ranging from 60 to
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100 MPa (the atmospheric pressure at sea-level is 0.1 MPa)228, 231. Since most
mesophilic proteins denature under such high temperatures 232 and pressures233, it
is intriguing to examine how proteins from hyperthermophilic organisms retain
activity. Previous studies have suggested structural characteristics 234-236 of
proteins that enable these extremophilic microbes to thrive in severe conditions.
However, there appears to be no universal adaptive mechanism, but rather a
complex combination of different factors, which frequently differs according to the
protein or protein family and is thus difficult to generalize 235, 237. Furthermore, the
role of dynamic characteristics such as conformational stability 238

239

and

flexibility240 for protein adaptability is still not well understood 228, 241.
Recent studies have reported that the conformational sub-states of a protein are
significantly perturbed by changes in temperature and pressure 6,

240, 242-245

.

Temperature enhances the internal fluctuations of a protein 1, and an optimum
temperature may provide an appropriate balance of flexibility and rigidity required
for function240, 246, 247. Temperatures higher than the optimum can lead to loss of
function through unfolding or denaturation 248. However, in the case of
hyperthermophilic proteins, high native-state flexibility can reduce their entropy of
unfolding, thus increasing their melting temperature 249. Similarly, high pressure
conditions can cause a protein to become inactive by the collapse of its intraprotein cavities, giving rise to an unfolded state 250. Pressure drives the reduction
in the volume of a protein, which results in a negative entropy change of the
system, which may destabilize the native state 251. Nonetheless, there are
exceptions, and the stability and/or activity of some proteins, such as a
thermolysin252 and a hydrogenase from Methanococcus jannaschii253, have been
shown to increase with pressure.
Overall, a dualistic picture of protein flexibility249, 254 and rigidity255, 256 has been
recognized as a possible factor behind the thermostability of thermophilic and
hyperthermophilic proteins240,

245

. On the one hand, flexibility is required by a

protein to function. On the other hand, flexible residues trigger protein unfolding
due to their large thermal fluctuations at high temperature. Hence, rigidifying
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flexible residues may be an effective way to improve thermostability 255, 256. In
addition to flexibility, oligomerization has been reported to be critically important
for the stability of some proteins257, 258 but the structure-based reasoning behind
this stability is not understood259.
We compare here a particularly interesting pair of proteins - the inorganic
pyrophosphatase

(PPase)

from

Thermococcus

thioreducens

(Tt),

a

hyperthermophilic archaea found near hydrothermal vents of the Mid-Atlantic
Ridge260, with a homolog from the mesophilic bacterium, Escherichia coli (Ec)261.
PPase (EC 3.6.1.1) is a homo-hexameric enzyme (~120 kDa), which catalyzes the
conversion of pyrophosphate into two phosphate ions. This conversion is important
for many critical biochemical processes, such as the production of proteins, nucleic
acid polymerization, and lipid metabolism260. Although TtPPase and EcPPase
have ~60% sequence similarity and ~40% identity and share similar oligomeric
crystal structures (Fig. 4.6), the temperatures and pressures for their optimal
enzymatic activities are very dissimilar. The catalytic activity of TtPPase has been
reported to be maximal at ~353 K but negligible (1.3% of the maximum activity in
10 mins) near room temperature and standard atmospheric pressure (1 bar or 0.1
MPa)

262

. In contrast, the optimal conditions for EcPPase have been shown to be

room temperature (298 K) and standard atmospheric pressure. Interestingly,
unlike other mesophilic proteins, EcPPase retains up to 95 to 100% of its
enzymatic activity at 353 K for about 10 minutes, after which the activity slowly
decays263.
Most crystal structures of thermophilic proteins have been resolved at room
temperature instead of at their native temperature or pressure conditions.
Therefore, to obtain a comprehensive picture of protein structure, dynamics, and
function, static structure determination (using X-ray and neutron crystallography)
must be complemented with dynamic information using various spectroscopic
techniques (e.g., neutron scattering240,
simulations49,

266

246

or NMR264,

265

) and computer

under varying external conditions. Molecular dynamics (MD)

simulation, which provides spatial and temporal information at an atomic
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resolution267 has thus become one of the most powerful methods to explore the
protein energy landscapes and their flexibility-function relationships52,

244, 245

at

near-native conditions and is the technique applied here.
Here, we perform MD simulations to understand the effects of pressure and
temperature on the structural and dynamic behavior of the two PPase homologs
in their native and non-native environments. We find that TtPPase possesses
higher global flexibility at both native and non-native conditions than its mesophilic
homolog (EcPPase). However, this effect is not reflected locally in the catalytic
pocket. Additionally, we determined that factors accompanying enzymatic activity
of PPase are the number of hydrogen bonds and water molecules in its catalytic
pocket. Furthermore, we provide potential factors behind the observed enzyme
activity and/or adaptability of EcPPase at high temperature and alternatively, the
inability of TtPPase to do so at low temperature.

4.3 Methods
All-atom MD simulations of monomeric and hexameric E. coli PPase (EcPPase)
and Thermococcus thioreducens PPase (TtPPase) were carried using GROMACS
(version 2016.3) suite145, 268. Analysis of the MD trajectories was performed using
python package pytraj204 and GROMACS analysis tools. Hexameric EcPPase
(PDB ID 1I6T261) and TtPPase (PDB ID 3Q5V260) were solvated in a TIP3P cubic
box of water (~150,000 atoms). The crystal structures for both the proteins were
resolved at the same conditions (298 K and 0.1 MPa) and are also in the same
space group (H32). The monomeric structures for both the proteins were modeled
by taking only one chain from the hexameric structures. These monomeric models
were then solvated in a TIP3P cubic box (~36,000 atoms).

Simulation details
All simulations were performed using the AMBER ff99SB potential 268. This
combination of AMBER ff99SB force-field and TIP3P water model has previously
been shown to work well, reproducing experimental results at different temperature
100

and pressure conditions

4, 269-271

. In ref 4, the adaptation of extremophilic protein

(Initiation Factor 6) at high temperatures (300 - 350 K) and pressures (0.1 – 100
MPa) agreed with experimental neutron scattering data. In ref

269

, the folding

thermodynamics and structure of Trp-cage in solution revealed that the stability of
peptide is more realistic in the simulation using TIP3P rather than using TIP4P-Ew
when compared to the calorimetry and circular dichroism (CD) spectroscopy
experiments

269

. The calculated partial molar enthalpy change and partial molar

volume change values of unfolding of chignolin reasonably agree well with the
results from CD spectroscopy and NMR experiments 270. Hata et al. 2020 studied
the pressure-induced dissociation of the CheY-FliM complex and found an
increased density of water in the first hydration shell 271. In each of the above
studies the force-field and water model used was the same as in the present work.
Each protein was simulated at four different conditions: two temperatures: 298 K
(ambient for EcPPase) and 353 K (ambient for TtPPase); and two pressures: 0.1
MPa (ambient for EcPPase) and 100 MPa (ambient for TtPPase). All systems were
prepared in a three-step process: initial energy minimization, NVT equilibration and
a NPT production run. Energy minimization was performed with the steepestdescent algorithm145, 268 to a tolerance of 1000 kJ/ (mol·nm). NVT equilibration was
performed for 1 ns at each temperature fixed with the V-Rescale thermostat158.
Following this step, the NPT ensemble protocol was followed to generate
production runs (500 nanoseconds for the hexamer and 1 microsecond for the
monomers) with the V-Rescale thermostat158 used to maintain the required
temperature and Parrinello-Rahman159 to maintain the pressure at 0.1 MPa or 100
MPa. Since the compressibility of water changes drastically with pressure, the
compressibility of water was taken to be 4.5 x 10-5 bar
5

bar

-1

-1

at 0.1 MPa and 3.5 x 10-

at 100 MPa, based on previous experimental work 272. Particle Mesh

Ewald273 was used for long-range electrostatics with a short-range electrostatics
and van der Waals cutoff of 1 nm. Three independent runs were performed for
each simulation (Table 4.2). The simulations were considered converged when
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the fluctuations in the root mean square deviation of C-alpha atoms (RMSDC)
reached a plateau with time.
Analysis details
Each of the metrics was calculated from the last 300 ns of each simulation
trajectory. The average value of each metric from 3 independent trajectories
starting with different velocities has been reported, where the standard error of the
mean has been used as the error bar.
The crystal structure RMSD comparison was performed using the SuperPose
websever274. The number of hydrogen bonds was computed using the “hbond”
utility in GROMACS using a donor−acceptor cutoff distance of 0.32 nm and a cutoff
angle of 20°. The solvent accessible surface area (SASA) and volume were
calculated using a 0.14 nm probe size for the whole protein. The volume of buried
cavities was determined using the “trj_cavity” module 275 in GROMACS. The
volume of the completely buried cavities (CBC) was calculated with a 1.4 Å grid
spacing (-spacing) and degree of buriedness of 6 Å. The number of water
molecules in the cavities was estimated by dividing the total cavity volume by the
volume of a buried water molecule near the protein surface (2.29 nm3) as reported
in previous work276. Intra and interchain hydrogen bonds were calculated using the
pytraj python package204. Inter chain hydrogen bonds were normalized by dividing
it by the number of chains (n=6).

4.4 Results
Structural flexibility
The structural flexibility of proteins is associated with many biological functions,
such as catalytic activity, substrate binding, and molecular recognition 1, 277. To
understand the effect of temperature and pressure on the protein global flexibility,
we calculated the average mean-square displacement (MSD) of the C

atoms.

The MSD is often used to compare the stability of thermophilic and mesophilic
protein homologs244, 245. Overall, the MSD results show that TtPPase has higher
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flexibility compared to EcPPase at all the conditions studied here (Fig. 4.1). This
is, therefore, an example of a thermophilic protein for which increased rigidity is
not associated with thermostability.
For both the homologs, a two-fold increase in MSD is observed at 353 K relative
to 298 K. Unlike temperature, the effect of pressure was less pronounced, an
increase in pressure causing a small reduction in MSD for TtPPase, and no change
for EcPPase. Interestingly, the MSD values for both the monomers showed an
effect of pressure at 353 K, contrary to the respective hexameric forms (Fig. 4.1
and 4.9). These results suggest that oligomerization may confer stability to
increased pressure at high temperature.
Flexibility is often correlated with activity or stability of mesophilic and thermophilic
homologs1,

277

. However, although at 298 K TtPPase is more flexible than

EcPPase, the activity of TtPPase is negligible near room temperature262. Further,
even though the flexibility of EcPPase at 298 K is smaller than that at 353 K,
EcPPase is catalytically active at both temperatures. Hence, the global flexibility
of the PPase does not follow the observed functional properties.
Compactness
Compactness is another common adaptive mechanism of thermophilic proteins259,
278

. To characterize the compactness of the hexameric structures over the course

of the simulations, we calculated the solvent accessible surface area (SASA) of
the proteins, which is inversely proportional to the number of native contacts279.
The density plots of the SASA show that EcPPase has larger solvent accessibility
than TtPPase, irrespective of the temperature and pressure conditions studied
here (Fig. 4.2a and 4.5b). A similar difference is found in the hexameric crystal
structures (TtPPase: 374 nm2 and EcPPase: 393 nm2; Table 4.3). However, the
solvent accessibility of EcPPase is reduced at 353 K compared to 298 K, whereas
that of TtPPase remains unaffected by the change in temperature. Pressure did
not significantly affect the SASA of either homolog. The SASA probability
distribution for monomeric structures showed a similar change in compactness, as
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observed in the hexameric form (Fig 4.8a). To further quantify compactness, we
calculated the number of intra- and inter-chain hydrogen bonds (HBs) of the
hexameric form. The normalized mean number of inter-chain HBs was nearly
double for TtPPase than for EcPPase and remained constant at all conditions (Fig.
4.2b), confirming the closer packing of the subunits in TtPPase than in EcPPase.
The mean number of intra-chain HBs did not change greatly between the two
homologs (Fig. 4.5a) at all pressure and temperature conditions. These results
suggest that the higher compactness of the TtPPase hexamer is due to
compactness between the subunits and also within each monomer.
Protein cavities
Intra-protein cavities have been recognized to be important for the stability and
function of proteins280, 281, and water molecules buried within these cavities have
been reported to be influential in temperature and pressure-mediated unfolding250,
282

. We calculated the number of water molecules enclosed in the completely

buried cavities of both proteins. This was found to be significantly higher for
EcPPase than TtPPase (Fig. 4.3) and not significantly affected by temperature and
pressure. These results are consistent with the inter-chain HB results discussed
earlier and with calculations that show that the crystal structure of TtPPase has
smaller buried cavity volume (303 water molecules) than EcPPase (427 water
molecules) (Table 4.3).
Flexibility in the catalytic pocket and its interaction with water
The precise 3D preorganization of residues and their interaction with water
molecules in an enzyme’s catalytic pocket determines the function 283-285. Previous
studies have identified conserved residues in the catalytic pocket of PPase
enzymes (Table 4.1 and Figs. 4.6a and 4.6b) that are critical for catalysis and are
also required for coordinating the divalent ions 286,

287

. Moreover, experimental

studies based on several crystal structures have shown that the hydrogen bond
network in the binding pocket is critical for hydrolysis and the catalysis requires
precise preorganization288,

289

. The catalytically inactive TtPPase at 298 K has
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~60% more HBs (~15 HBs, i.e., 2.5 per monomer) between the catalytic residues
than the catalytically-active forms of PPasse (TtPPase at 353 K, and EcPPase at
298 and 353 K) (Figs. 4.4 a, c). These results, for the hexameric form were also
found in the simulations of the monomeric form (Fig. 4.8b). We did not observe
any effect of pressure on the number of HBs between the residues in the catalytic
pocket (Figs. 4.4 a, c).
Water molecules in the catalytic pockets can be critical for enzymatic function 290,
291 292

,

. Interestingly, the catalytic pockets of both homologs have ~110

protein:water HBs at 353 K, consistent with the observed catalytic activity of
EcPPase at this elevated temperature 263. However, at 298 K, EcPPase
significantly increases the number of protein:water HBs, to around ~160 HBs,
whereas TtPPase does this to a much lesser degree, to ~130 HBs (Figs. 4.4 b,
d). We also quantified the flexibility and solvent exposure of the catalytic pocket by
calculating the root mean square fluctuation (RMSF) of these conserved residues.
The RMSF of these residues in EcPPase varies weakly with temperature, whereas
TtPPase has significantly lower fluctuations at 298 K compared to 353 K (Fig. 4.7).
EcPPase therefore maintains its local flexibility of the catalytic pocket at both
temperatures, whereas TtPPase becomes rigid at the lower temperature.

4.5 Discussion and Conclusions
In this work, we compare structural and dynamic properties of hyperthermophilic
and mesophilic PPases using MD simulations mimicking deep-sea and ambient
conditions. The results indicate that TtPPase has been designed to function at high
temperatures with a more compact structure and a reduced number of intra-protein
hydrogen bonds in the catalytic pocket. However, TtPPase does not maintain both
of these properties at room temperature, where it cannot catalyze the enzymatic
reaction. Interestingly, we found EcPPase adapts and retains its activity at high
temperature by incorporating similar strategies used by TtPPase to function at high
temperature: maintaining hydrogen bonds in the catalytic pocket and increasing its
compactness.
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The overall structural flexibility of a protein is sometimes assumed to be relevant
for its enzymatic activity1 and the MSD is often used to quantify this. A general
framework for understanding the stability and function of hyperthermophilic
proteins in their native conditions has been proposed based upon the hypothesis
that enhanced rigidity underlies increased thermal stability 249. However, other
experimental and computational studies have reported that hyperthermophilic
proteins have larger conformational flexibility than their mesophilic homologs 245,
293

. Here, we also observe higher overall flexibility of TtPPase than EcPPase at all

temperature/pressure conditions. Indeed, even at room temperature, where
TtPPase is enzymatically inactive, it is more flexible than EcPPase. Thus,
differences in the overall flexibility of PPase are not directly associated with
differences in its enzymatic activity.
Although the crystal structures of both homologs were not resolved at their native
conditions, the RMSD between them is small (0.18 nm), and both homologs have
similar radii of gyration (2.9 nm). However, the buried cavity size and solvent
accessibility of the crystal structure of EcPPase are greater than for TtPPase.
Likewise, from the simulations, the solvent-accessible surface area and number of
inter-chain HBs (both of which are related to compactness) of TtPPase indicate
that it is more compact than EcPPase at all the conditions investigated here. The
main contributing factors to the compactness of TtPPase are inter-subunit
compaction, as shown by increased inter-chain HBs, together with the reduced
solvent-exposed surface area of each monomer as demonstrated by the
simulations of the monomeric forms. These results are not surprising since
compactness is a known adaptive factor in common between many thermophilic
proteins.
Moreover, a decrease in the number of water molecules in the buried cavities of
TtPPase compared to EcPPase was observed at all conditions. These results are
consistent with previous work
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which showed that proteins that are active at

extremely low temperatures (psychrophilic proteins) have a comparatively larger
average cavity size and the properties of water buried in the protein cavities of a
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hyperthermophilic protein significantly differ from its mesophilic homolog

295, 296

.

Similarly, a reduction in buried cavity volume has been reported as an adaptation
(thermostability) mechanism at high-temperature conditions because large waterfilled cavities are known to be a driving factor for protein denaturation at high
temperature and pressure 297.
Interestingly, EcPPase exhibited a change in its compactness with a change in
temperature, becoming more compact at a higher temperature than at its native
temperature. In contrast, the compactness of TtPPase remains the same at room
and high temperatures. Additionally, we also studied the structure and dynamics
of the catalytic pocket. Here, we observed an increase in rigidity at 298 K compared
to 353 K, as shown by the lower RMSF of catalytic pocket residues and a greatly
increased number of HBs between the catalytic pocket residues. In contrast, we
observed similar catalytic pocket residue HBs in EcPPase as for TtPPase at 353
K, and this number remained unaltered upon a change in temperature. This local
flexibility (based upon the number of HBs and RMSF) of the catalytic pocket agrees
with the existing “corresponding states” hypothesis, according to which a
thermophilic protein has a more rigid catalytic pocket than its mesophilic homolog
at room temperature298. However, both of these homologs should exhibit similar
flexibility at their respective functional temperatures 298. Furthermore, we see that
the trend observed in global flexibility measured by the MSD is not reflected locally
in the catalytic pocket (i.e., there is no direct correlation between local and global
motions).
The above picture is further supported by calculations of the number of HBs of the
catalytic pocket residues with water molecules. In the case of EcPPase, we
observe a dramatic decrease in the number of HBs with water at 353 K when
compared to 298 K, whereas there is a negligible change for TtPPase. This result
is consistent with the compactness results showing that EcPPase has the
capability to adapt to a high temperature, whereas TtPPase lacks the ability to
adapt to a low temperature environment.
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Based on these results, we suggest that at lower temperatures, both of these
homologs would need comparatively more water molecules in their catalytic
pockets and a larger exposed surface area to function and that the opposite is
needed at higher temperatures. EcPPase is able to make the aforementioned
changes to its structure and hence is able to adapt to high temperature/pressure,
but TtPPase fails to do so at low temperature. Although the overall structure of
TtPPase barely responds to change in temperature/pressure, the catalytic pocket
becomes more rigid at 298 K than at 353 K due to an increase in the number of
intra-protein HBs. This rigidity may explain its enzymatic inactivity at room
temperature. In contrast, EcPPase adapts to a high temperature by reducing
solvent-exposed surface and adopting a more compact oligomeric structure. In
addition, EcPPase preserves the number of hydrogen bonds within the residues in
the catalytic pocket at all the conditions and reduces its interactions with water
molecules at a higher temperature. This provides a possible explanation behind its
activity even at a high temperature. Nevertheless, the current work does not
provide information on the rate-determining step (i.e., hydrolysis of pyrophosphate
288

) but focuses on the local environment and the preorganization of the catalytic

pocket prior to hydrolysis which has been known to be important for activity 288, 289.
We observed an effect of pressure on the MSD of monomeric form, but not for
hexameric form. However, the SASA and the catalytic pocket behavior of the
monomeric and hexameric forms are relatively unaffected. Consequently, our work
sheds little light on the effect of pressure on oligomerization in the case of PPase.
Overall, our results suggest the change in temperature significantly affects the
conformational properties of PPase homologs, whereas the effect of pressure is
very subtle or insignificant in vitro. However, pressure can have a significant impact
on PPase in a cellular environment. Indeed, previous studies have shown that the
archaeon Thermococcus barophilus accumulates osmolytes inside the cell to
adapt and function under varying stress (pressure and temperature) conditions 299,
300

.
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Finally, our results provide a structural and dynamic basis for the experimentally
observed activity of EcPPase at both high and room temperature. Such an
intriguing ability of adaptation of mesophilic PPase could be possibly explained by
existing evolutionary theory since hyperthermophilic archaea are thought to be a
universal ancestor301. Indeed, recent work302 has suggested that thermophilic
proteins (isolated from thermophilic archaea Pyrococcus furiosus) were ‘‘de novo’’
designed in a hot environment and then used a “structure-based mechanism” to
adapt to a mesophilic environment on recolonization. In

the structure-based

mechanism adaptation to high temperatures is through compaction, which here is
mostly inter-subunit, with the monomer structures relatively unchanged.
Phylogenetic analyses303 show that T. thioreducens (also hyperthermophilic
archaea) shares the same clade as P. furiosus; hence, PPase homologs studied
here may have evolved according to the structure-based adaptation theory. Thus,
EcPPase may have been evolved from its ancestral counterpart TtPPase to
recolonize at room temperature and may, therefore, be able to adapt when
introduced to a higher temperature. Moreover, since thermophiles do not live at
room temperature, there is no selective need for high activity at room temperature.

109
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Figure 4.1 Mean square displacement (MSD) of C-alpha atoms for (a)
hexameric TtPPase and (b) hexameric EcPPase. Higher values of MSD for
TtPPase at all conditions indicate higher structural flexibility than EcPPase.
Error bars shown in this and the subsequent figures are the standard error
of the mean, and those not immediately visible are at most the size of the
symbol.

Figure 4.2 a) Probability distribution for solvent accessible surface area
(SASA) of the hexameric forms for TtPPase (triangle) and EcPPase (circle);
b) The normalized number of interchain hydrogen bonds.
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Figure 4.3 Number of water molecules in completely buried cavities of
hexameric form at different temperature and pressure conditions. TtPPase
(black shaded bars) vs. EcPPase (red shaded bars).
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Figure 4.4 Probability distributions of the number of hydrogen bonds
between the residues in the catalytic pocket: hexameric EcPPase (a) and
hexameric TtPPase (c). Probability distributions of the number of hydrogen
bonds between the catalytic pocket residues and water molecules in the
catalytic pocket: hexameric EcPPase (b) and hexameric TtPPase (b).
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Figure 4.5 Mean number of hydrogen bonds within each chain (intrachain)
for hexameric TtPPase and hexameric EcPPase at different conditions; b)
Probability distribution for solvent accessible surface area (SASA) of the
hexameric forms for TtPPase (triangle) and EcPPase (circle); Error bars
show the standard error of the mean (SEM), and those not immediately
visible are the same size of the symbol. The cutoff distance of 0.32 nm and a
cutoff angle of 20° was considered for hydrogen bond analyses.
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Figure 4.6 a) Sequence alignment of EcPPase (Ec) and TtPPase (Tt) showing
identical residues (in red box), similar residues (in white box) and conserved
catalytic pocket residues (black arrow); b) Catalytic pocket of EcPPase (red)
and TtPPase (blue) showing conserved critical residues (as sticks) and
hydrogen bonds (black dotted line); c) TtPPase hexameric crystal structure
with each subunit colored in different color.
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Figure 4.7 Root mean square fluctuation (RMSF) of all atoms of catalytic
pocket residues (averaged over per residue) for hexameric TtPPase (top) and
hexameric EcPPase (bottom) at different conditions.
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Table 4.1 Binding pocket residues used for the calculations
Protein

Binding pocket residues

EcPPase

Asp 42,65,67,70,97,102
Glu 20,31
Arg 43
Lys 29, 104,142
Tyr 55,141

TtPPase

Asp 43,66,68,71,98,103
Glu 22, 32
Arg 44
Lys 30,105,141
Tyr 56, 140

Table 4.2 Molecular dynamics simulations details
System

298K (0.1 and 100 MPa),

type

353K (0.1 and 100MPa)

Hexamer

500 ns

3

Monomer

1000 ns

3
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Replicates

Table 4.3 Hexameric crystal structure comparison
Properties

Ec (1I6T)

Tt (3Q5V)

Residues

1049

1062

Mass (KDa)

117.3

124.2

Radius of gyration (nm)

2.9

2.9

SASA (nm2)

393

374

# of water in CBC

427

303

33

42

#

of

Hbonds

between

catalytic pocket residues
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5 Early Stage Structure-Based Drug Discovery
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5.1 Competitive inhibitors for Serine-Rich Repeat (Srr) Adhesin
A version of this chapter was originally published by me:
Agarwal, R., Bensing, B. A., Mi, D., Vinson, P. N., Baudry, J., Iverson, T.
M., & Smith, J. C. Structure based virtual screening identifies novel competitive
inhibitors for the sialoglycan binding protein Hsa. Biochemical Journal (2020)
In this work, I have designed the computational strategies, performed all analysis,
and written the paper; BAB: made substantive contributions to the manuscript’s
content; DM and PNV: performed screening assay and helped in result
interpretation; TMV: conceived the idea and made substantive contributions to the
manuscript’s content; JB and JCS: provided help in results discussion and edited
the manuscript.
5.1.1 Abstract
Infective endocarditis (IE) is a cardiovascular disease often caused by bacteria of
the viridans group of streptococci, which includes Streptococcus gordonii and
Streptococcus sanguinis. Previous research has found that a serine-rich repeat
(SRR) proteins on the S. gordonii bacterial surface play a critical role in
pathogenesis by facilitating bacterial attachment to sialylated glycans displayed on
human platelets. Despite its important role in disease progression, there are
currently no anti-adhesive drugs available on the market. Here, we performed
structure-based virtual screening using an ensemble docking approach followed
by consensus scoring to identify novel small molecule effectors against the
sialoglycan binding domain of the SRR adhesin protein Hsa from the S. gordonii
strain DL1. The screening successfully predicted nine compounds which were able
to displace the native ligand (sialyl-T antigen) in an in vitro assay and bind
competitively to Hsa. Furthermore, hierarchical clustering based on the MACCS
fingerprint showed that eight of these small molecules do not share a common
scaffold with the native ligand. This study indicates that SRR family of adhesin
proteins can be inhibited by diverse small molecules and thus prevent the
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interaction of the protein with the sialoglycans. This opens new avenues for
discovering potential drugs against infective endocarditis.
5.1.2 Introduction
Infective endocarditis (IE) (or bacterial endocarditis (BE)) is a life-threatening
infection of cardiac valves and the interior surface of the heart (endocardium) 178.
Oral streptococci account for ~17-45% of all cases of IE304,
infection destroys the valves and results in heart failure 180,

305

. If untreated,

306, 307

. Moreover,

bacteria may also form clots (emboli) that enter the blood stream and produce
strokes. IE affects 10,000-20,000 patients in the US every year and is associated
with an in-hospital mortality rate of ~20% and a five year mortality rate of ~40-70
%178, 308, 309. Treatment for endocarditis currently requires prolonged antimicrobial
therapy, often combined with surgery. The rise in antibiotic resistance310 has
limited our pharmacological options311, 312, and resistant organisms have increased
the mortality rate313. Although medical therapy alone often resolves infection, 47%
or more of the patients eventually require valve replacement due to the damage
incurred306, 307, 314. Given the associated morbidity and rising mortality rate, there
is an urgent need to develop novel therapies against IE.
Previous studies have reported that the binding of bacteria to host platelets
contributes to the colonization of damaged aortic valves 180. A cell wall-anchored
serine-rich repeat (SRR) protein mediates the adherence of S. gordonii and S.
sanguinis to sialoglycans displayed on the human platelet216 glycoprotein GPIb181,
182

. SRR proteins have been demonstrated to be virulence factors for

endocarditis181, 182, and disrupting the interaction between the SRR protein and
sialoglycans on host platelets may therefore reduce virulence. Streptococcus
gordonii is one of the well-studied species that cause IE and is a normal component
of the human oral microbiota183. Platelet binding by S. gordonii strains M99 and
DL1 are facilitated by the homologous SRR proteins GspB and Hsa,
respectively315. Although these adhesins have high sequence identity, their ligand
binding regions (BRs) differ significantly and have different sialoglycan
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selectivity181, 195, 205. GspB binds with narrow selectivity to sialyl-T antigen (sTa)
whereas Hsa binds promiscuously to a range of glycans181, 195, 205. Anti-adhesive
therapies have been explored for the treatment of a wide range of other bacterial
infections226, 316, 317, but have not yet been pursued for IE. Anti-adhesives can, in
principle, complement traditional antibiotics and improve their efficacy, potentially
eliminating the need for surgical intervention. Moreover, an inhibitor might also
reduce "re-seeding" (bacteremia is a hallmark of IE), or could be used as a
prophylactic in some situations. Additionally, anti-adhesive agents are not
bactericidal and hence the propagation and spread of resistant strains is much less
likely to occur than as a result of exposure to bactericidal agents, such as
antibiotics.
The crystal structures of the BRs (HsaBR (PDB 6EFC)198, GspBBR (PDB 6EFA)198,
10712BR (PDB 6EFF)198, SK150BR (PDB 6EFB)198, SrpABR (PDB 5EQ2)196, and
SK678BR (PDB 6EFI)198) from a number of S. gordonii and S. sanguinis SRR
proteins have been solved196,
associated

with

sialoglycan

198, 206

. These all have two domains

binding:

the

Siglec

(Sialic

which

are

acid-binding

immunoglobulin-like lectin) domain and the Unique domain (for which function is
not known completely). Furthermore, recent studies have identified that the three
loops (CD, EF and FG) adjacent to the sialoglycan binding site are critical for the
affinity and selectivity between ligands198. Additionally, it has been reported that a
partially conserved “YTRY” motif in the binding site is necessary for formation of
hydrogen bond interactions with the sialic acid of the native ligand 198 and a crystal
structure of HsaBR bound to sTa (PDB 6EFD198) has been resolved showing these
interactions. Importantly, there are also human sialoglycan-binding proteins318,
that contain a sialoglycan binding site but the site differs significantly in both
geometry and in the location of hydrogen-bonding donors and acceptors from that
found in the streptococcal Siglec-like proteins197. Moreover, the mode of interaction
with sialoglycans is distinct between human Siglecs and bacterial sialoglycan
binding adhesin proteins197.
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These structural information can be leveraged by structure-based approaches to
the identification of new molecular effectors to target SRR adhesin proteins. In our
current pipeline, we targeted the BR of the well-characterized SRR protein Hsa
(HsaBR), using in-silico virtual screening of ~105,000 small molecules, with the goal
to predict and prioritize which small molecules could bind to Hsa BR and disrupt its
interactions with sialoglycan. Moreover, since Hsa BR binds promiscuously to many
glycans using a conformation selection mechanism198 and crystal structure of both
the apo and holo forms exists, it is potentially a good target for such a chemical
biology approach.
Here, instead of using only the crystal structure in our computational approaches,
we used molecular dynamics (MD) simulations to describe the flexibility of the
binding pocket and generate an ensemble of protein conformations, which has
been shown to yield large and diverse sets of molecular effectors to control protein
functions

74, 319

. Following subsequent high throughput ensemble docking, we

prioritized the compounds using consensus scoring, which has previously shown
to reduce the number of false positives and increase the success rate 320. To further
improve our predictions, we cross screened the compounds against the BRs from
five Hsa homologues and identified compounds which bound to Hsa BR with
relatively higher docking scores compared to other BRs. From our virtual screening
predictions, we were able to achieve a high success rate of ~20%, finding that 9
out of 50 compounds that were suggested for experimental validation were indeed
able to displace the native ligand from the Hsa BR binding pocket. Moreover, we
were also able to identify scaffolds distant from the native ligand that bind to HsaBR.
To our knowledge, these are the first small molecules described to inhibit binding
of SRR family of adhesin protein to its native sialoglycan.
5.1.3 Methods
System preparation and molecular dynamics simulation
Crystal structures of the sialoglycan binding proteins HsaBR (PDB 6EFC)198,
GspBBR (PDB 6EFA)198, 10712BR (PDB 6EFF)198, SK150BR (PDB 6EFB)198, SrpABR
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(PDB 5EQ2)196, and SK678BR (PDB 6EFI)198 were used in this study. Molecular
dynamics (MD) simulations was performed on all these proteins using the
Amber14 ff14SB force-field parameters58,
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. Each of these proteins was

surrounded by an octahedral box of water model TIP3P200 of 10 Å. First, the protein
structure was held fixed with a force constant of 500 kcal mol -1 Å-2 while the system
was minimized with 500 steps of steepest descent followed by 500 steps with the
conjugate gradient method. In the second minimization step, the restraints on the
protein were removed and 1000 steps of steepest descent minimization were
performed followed by 1500 steps of conjugate gradient. The system was heated
to 300 K while holding the protein fixed with a force constant of 10 kcal mol -1 Å-2
for 1000 steps. Then, the restraints were removed, and 1000 MD steps were
performed. The SHAKE algorithm201 was used to constrain all bonds involving
hydrogen in the simulations. 200 ns production MD was performed at 300 K using
the NPT ensemble and a 2 fs time step with nonbonded cutoff of 10 Å. The
temperature was fixed with the Langevin dynamics thermostat202 and the pressure
was fixed with a Monte Carlo barostat203. Similar MD simulation protocol was used
on all the adhesin. This procedure yielded a total of 20,000 snapshots for
subsequent analyses. Three independent runs were performed for each
simulation.

In silico screening
Ensemble docking is an in-silico structure-based chemical biology method using
an ‘ensemble’ of protein target conformations to discover novel protein effectors 74.
The workflow used is shown in Fig. 1. The ensemble was constructed by clustering
snapshots from molecular dynamics (MD) simulation trajectories by root mean
square deviation (RMSD) of the binding pocket residues and loops (Table S1)
surrounding the binding pocket with the hierarchical agglomerate clustering
algorithm using Cpptraj module204.
The Vanderbilt small molecule collection (“The Discovery Collection”) containing
~105,000 compounds was docked to an ensemble of 5 conformations (4
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representative structures obtained from clustering from MD and 1 crystal structure)
with a cubic box with edges of ~30 Å. This small molecule library has been used
in multiple high-throughput screens resulting in hits that have moved to hit-to-lead
stages of early drug discovery programs321-323. The docking box was centered on
the C⍺ atom of conserved residue THR 339 (Hsa numbering). VinaMPI 324, a
parallel version of AutodockVina90, was used to perform the in silico screening.
Similar docking procedure was performed for all the adhesin proteins. The docked
poses were then ranked by the AutodockVina scoring function 89. The compounds
were not only screened for HsaBR but also cross screened with 5 adhesin proteins
(GspBBR, 10712BR, SK150BR, SrpABR, SK678BR). The cross screening was
performed to remove the promiscuous compounds or “frequent hitters” ( i.e.,
compounds which are always scored high for all the target) and thus reducing the
number of false positives325. However, it must be noted that the goal of the cross
screening was not to get selectivity towards Hsa BR.From this ranked list of
compounds, we tested compounds which were within the top 1% (~1050
compounds) for HsaBR but not within the top 1% of the other 5 BRs (GspB BR,
10712BR, SK150BR, SrpABR, SK678BR) and narrowed the list down to 250
compounds.We note that we only experimentally tested binding to Hsa BR and not
the selectivity of the predicted binders. Next, the resulting ~250 compounds were
refined and rescored using two MOE scoring functions 86. The non-polar hydrogens
(not included in Vina docking protocol) were added before performing the “induced
fit” docking protocol in MOE86. The docking poses were ranked using “GBVI-WSA
dG” and “Affinity DG” scoring functions86. Using consensus scoring, the top 50
compounds were then suggested for experimental validation. A flowchart of the
screening methodology used is shown in Fig. 5.1.

Cheminformatics
All the physicochemical properties and fingerprints of small molecules were
calculated using combination of MOE86, ChemBioServer326 and RDkit327. MACCS
fingerprints were calculated for each compound and similarity between them were
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compared with the Tanimoto coefficient, followed by hierarchical clustering to
cluster the similarity matrix.

Experimental assays
Protein expression and purification
GST-tagged HsaBR was expressed and purified as described in ref 195. GST-HsaBR
was expressed under the control of the pGEX-3X vector in E. coli BL21 (DE3) in a
Terrific Broth medium with 50 µg/ml kanamycin at 37 °C. When the OD 600 reached
1.0, expression was induced with 1 mM IPTG at 24 °C for 5 hrs. Cells were
harvested by centrifugation at 5,000  g for 15 min, optionally washed with 0.1 M
Tris-HCl, pH 7.5, and stored at –20 °C before purification. The frozen cells were
resuspended in homogenization buffer (20-50 mM Tris-HCl, pH 7.5, 150-200 mM
NaCl, 1mM EDTA, 1 mM PMSF, 2 µg/ml Leupeptin, 2 µg/ml Pepstatin) then
disrupted by sonication. The lysate was clarified by centrifugation at 38500  g for
35-60 min and passed through a 0.45 µm filter. Benchtop purification was
performed at 4 °C using Glutathione Sepharose 4B beads, with pure GST-Hsa
were eluted with 30 mM GSH in 50 mM Tris-HCl, pH 8.0.

AlphaScreen high-throughput screening assay
We used the AlphaScreen modification of an ELISA as the primary target-based
proximity assay to monitor ligand displacement. AlphaPlate (Cat # PE 6005351,
Lot # 8220-16081) with 384-well was used for the screening. In the experimental
setup, biotinylated sialyl T antigen (sTa) was coupled to a streptavidin donor bead
and GST-tagged Hsa was coupled to an anti-GST conjugated acceptor bead in
PBS (phosphate buffered saline). The reaction was excited at 680 nm to stimulate
singlet oxygen-mediated energy transfer to the acceptor bead, which can be
detected at 615 nm.
The dose-dependent signal reflects the number of bead-coupled adhesins bound
to bead-coupled glycans. To determine the optimal ratio of Hsa-GST to biotinylated
sTa for occupying binding sites on the beads and, therefore, maximal signal
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production, the Hsa-GST concentration was titrated in a 10 point-3 fold dilution
starting from 1000 nM and the biotinylated sTa concentration was titrated in a 9
point-3 fold dilution starting from 100 nM and the resulting Alpha signal measured.
The maximal signal, representing the “hooking point” where either the donor or
acceptor beads are saturated, was found to be 3 nM for Hsa-GST and 3 nM for
biotinylated sTa. The final chosen concentrations used in the screen was 1 nM of
Hsa-GST and 2 nM of biotinylated sTa, slightly below the hook point, to avoid
potential excess Hsa that may sequester inhibitors and interfere with signal
disruption. DMSO was used as the negative control and unbiotinylated sTa was
used as a positive control at a concentration of 30 uM which was determined to
provide maximal disruption of the Alpha signal.
We applied this assay to the evaluation of the test compounds that were predicted
as binding to HsaBR using virtual screening. This initial screen was performed with
all test compounds in duplicate at a final concentration of 10 M and DMSO was
used as the negative control and unbiotinylated sTa was used as a positive control.
Z’ factor calculation
The Z’ factor328 is an indicator of high throughput screening assay performance
and was calculated as follows:
𝑍′ = 1 − 3(𝛿𝑝 + 𝛿𝑛 )/ |(𝜇𝑛 − 𝜇𝑝) |
The standard deviations and means of the positive (p) and negative (n) controls
are denoted by 𝛿𝑝 , 𝜇𝑝 and 𝛿𝑛 , 𝜇𝑛 respectively. DMSO and untagged sTa are
the positive and negative control respectively.

Effector identification analyses
The alpha value of each test compound was measured and was filtered using 1fold, 2-fold or 3- fold of either standard deviation (SD) from the mean of the
negative control group, or absolute deviation from the median (MAD) of negative
control group. We determined which tested points lay outside the mean of the
vehicle control (there were 9 replicates of the negative control (DMSO), 4
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replicates of the positive control (untagged sTa)). We used a threshold of both 3
SD and 3 MAD from the negative control group. This was followed by taking the
union of the two. Then, it was further filtered by only keeping those molecules
which hit twice in the confirmation duplicates. Finally, we calculated the
Percentage Control from the control group to identify compounds that disrupted
the Hsa-sTa interaction. This serves as an initial hit identifier but should be
followed-up to confirm true actives and rule out false positives.
Percentage control (PC) calculated as follows:

where, 𝛼 is the average alpha value for negative control (𝛼𝑁𝐶 ), positive control
(𝛼𝑃𝐶 ) and compounds tested (𝛼𝐶𝑜𝑚 ). PC is a measure of the alpha signal of the 10
M test compound in percentage of the controls.
5.1.4 Results and Discussion
Protein dynamics and conformations
We used MD simulations to capture the internal dynamics of the proteins and find
binding site conformations not seen in the crystal structure 49. We calculated the
root mean square fluctuation (RMSF) to identify the flexible regions (Fig 5.2a).
Although the overall structure of the Siglec domain is rigid, we observed that the
loops (CD, EF and FG) close to the binding pocket are flexible for all the adhesin
proteins (Fig 5.2a, 5.6).
In the case of HsaBR, we observed that the CD and EF loops constitute the most
flexible region of the protein. Moreover, critical binding pocket residues other than
in these loops were identified from the crystal structure of Hsa BR and the native
ligand (sTa) (Table 5.2).
To capture new conformations of the binding pocket that deviate from the initial
crystal structure, the root mean square deviation (RMSD) of the loop residues and
other critical residues (previously known to bind to the native ligand) (Table 5.2)
were used to cluster the MD trajectories. The clustering resulted in four different
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clusters. The structure closest to the centroid of each cluster was used for docking.
The “ensemble” of structures obtained from clustering and crystal structure were
superimposed to observe the deviation of structures (as shown in Fig 5.2b). We
observe that all the structures had similar secondary and backbone structures and
the RMSDCalpha of the Siglec domain was calculated to be within ~1.5 Å. However,
as seen in the superimposed structures (Fig 5.2b), the loop regions (especially CD
and EF loop) have different orientations in the “ensemble” when compared to the
crystal structure. Similarly, we observed that the side chains in the binding pocket
residues orient differently between the structures, which can be critical for rigid
body docking.

Physicochemical properties of small molecule database
The five structures obtained from MD simulations and the existing crystal structure
were screened against the Vanderbilt small molecule collection (“The Discovery
Collection”) containing ~105K compounds. Although, this database has been used
in several early drug discovery programs 321-323, it has not been characterized yet.
Therefore, before performing the virtual screening, and although the goal of the
present work is just to identify a molecular effector, we wanted to calculate the
physicochemical properties to understand its use as a potential drug precursor for
future studies. Firstly, we calculated the molecular weight (MW) of the compounds
(Fig 5.3a), which is known to be critical for safety and tolerability reasons82. The
Vanderbilt database has compounds with MW less than 500 Da that are
considered to improve druglikeness329, 330 and also has low MW compounds (<300
Da) that are considered better initial precursor because they serve as effective
chemical starting points for lead optimization331. The polar surface area and the
number of rotatable bonds have been found to better discriminate between
compounds that are orally active332. It has been predicted that compounds with 10
or fewer rotatable bonds and those having a polar surface area of less than 140
Å2 have a good oral bioavailability332. In our database, we observed that most
compounds had a mean polar surface area of ~150 Å 2 and less than 10 rotatable
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bonds (Figs 5.3b, c). Lipophilicity (SLogP) is another factor which is known to
influence drug potency, pharmacokinetics, and toxicity 329,

333

. Compounds with

SLog P values between −0.4 to +5.6 range are known to be more “druglike” 330, 334.
Here, we found that most of the compounds fall within this range (Fig 5.3d).
Although the above is a set of physicochemical properties that are considered to
be important for different aspects of druggability, there have been numerous FDA
approved drugs which violate one or more of these rules335, 336.

Docking results and poses
After our virtual screening, we first ranked all the top poses for each compound
based on the Autodock Vina scoring function 89. Subsequently, we selected those
compounds (~250) that were in the top 1% for Hsa BR but did not rank within the
top 1% for any other adhesin protein (GspBBR, 10712BR, SK150BR, SrpABR,
SK678BR). This was followed by implementing consensus scoring in which the
poses (obtained from AutodockVina) were energy-minimized and then rescored
using two MOE scoring functions86 (as mentioned in the Methods section). In the
end, compounds that ranked within the top 50 for all the three scoring functions
were suggested for experimental validation. Next, we examined the number of
electrostatic intermolecular interaction (hydrogen bonds (HBs) and Pi (π-π/ π-H/πcation)) which are important for protein-ligand binding337-339. The importance of
hydrogen bonding in drug design is well recognized and the hydrogen-bonding
capabilities deeply influence the transport and ADME (Adsorption, Distribution,
Metabolism and Excretion) properties of a molecule as well as its specific
interaction with biological receptors340. Many QSAR studies have been reported in
which hydrogen-bonding interactions play a key role in modeling a particular target
activity341, 342. Therefore, we calculated the number of compounds which form an
interaction with the residues known to bind (or in close proximity) sTa to get
information about which residues were targeted the most and are easily accessible
to interact with a small molecule (Fig 5.10). Thr 339, Tyr 337 and Lys 335, which
form HBs with the native ligand (sTa) in the crystal structure (PDB 6EFD) 198 as
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shown in Fig. 5.4a, are also some of the residues which form interactions (HBs or
Pi) with majority of the compounds. Moreover, from our strategy we found that
majority of the compounds form 3 or more HBs or Pi interactions with the binding
site residues, whereas 10 compounds make more than 5 HBs or Pi interactions
(Fig. 5.4b). Furthermore, out of these 50 compounds, 25 compounds (50%) were
predicted to bind to two of the “ensemble” structures generated from MD
simulations with higher score than to the crystal structure. This further illustrates
the usefulness of using ensemble docking.
Experimental validation
Alpha assay screening was performed for the top 50 compounds predicted to
displace sTa (the highest affinity native ligand) from HsaBR. The Z’ factor value of
the DMSO (negative control) versus untagged sTa (positive control) was 0.32,
which denotes that there is a separation between the high and low signals of the
assay in that 3x the sum of the standard deviations of the high and low signals of
the assay divided by the difference of the mean of these two experimental groups
is 0.68 (the error is relatively small compared to the separation of the mean of the
two groups).
After filtering the small molecules using the experimental data based on the
percentage control (PC), nine small molecules were retained. These nine
compounds showed a statistically significant decrease in the signal when the two
replicates were averaged (Fig. 5.5). These compounds have a PC three standard
deviations outside the mean of the negative control (DMSO).
The IC50 of the untagged sTa (positive control) was calculated as 8.67 M (Fig.
5.7a). At 10M concentration, the PC was 39% (Fig. 5.7b). At the same
concentration, the PC of the 9 small molecules ranges from 23% to 70% and, out
of these, two compounds have PC values of less than 39% and one has a PC of
41% (Table 5.3).
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Computational and binding pose analyses of experimentally validated
effectors
The nine small molecules were screened for 25 known toxic and carcinogenic
fragments, such as anthracene, quinone, hydroquinone, butenone--Michael
acceptor, chloroethane--Michael acceptor326. Of the 9 experimentally validated
compounds (C1-C9) (Table 5.1), only Compound 1 (C1) was identified as
potentially toxic, containing a benzo-dioxane and a catechol group. Moreover, to
test the similarity between these effectors and the native ligand, fingerprint-based
hierarchical clustering was performed. We found four clusters (as shown in Fig.
5.8), which showed that the compounds identified from the screen are diverse
among themselves and are not similar to the native ligand. Additionally, we also
tested the compounds for Lipinski’s rule 330, to evaluate druglike-ness of the
compounds. C4 was the only molecule with one violation (with 11 hydrogen bond
acceptors), whereas all the other compounds satisfied all the 4 rules.
Following the above cheminformatics analyses of the experimentally validated
effectors, we examined the computational models of the best poses and the
interactions of the nine small molecules shown to have inhibition experimentally
(Fig. 5.11 and Table 5.1). Interestingly, the inhibitor binding site is adjacent to the
sTa binding site (Fig. 5.9) but both the sites does partially overlap. This site can
be further explored for more selective inhibitors in future studies.
Next, we calculated interaction map of each of the nine effector and looked at the
hydrogen bonds between the ligand and the side chain and backbone atoms of the
binding site residues. In the models C1, C2, C4, and C5 form backbone HBs with
Asp 255 and compounds C2-4 form backbone HBs with Val 367 while other
compounds (C1, C5-9) form side chain HBs with Val 367. Interestingly, C3 forms
four backbone HBs with Gly 362, Phe 366 and Val 367, and five sidechain HBs
with Tyr 337, Thr 339, Ser 253, Asn 361 as shown in the interaction map (Fig. 5.11
and Table 5.1). Other residues that form HBs with most of the compounds are Thr
339, Val 285 and Asn 361 (Fig. 5.11 and Table 5.1). The interaction maps of all
the nine small molecule effectors are shown in Fig. 5.11. The orientation of the
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best docked pose of the nine validated effectors and crystal structure pose of the
native ligand in the binding pocket are very different and bind in adjacent sites (Fig.
5.9). However, the residues that form HBs with the effectors, also form HBs with
native ligand or are in close proximity of it. Hence, it is likely that these nine
compounds are able to displace the native ligand in part because they form HBs
with these critical residues.
5.1.5 Conclusions
The SRR protein Hsa has been considered an attractive molecular target for drug
discovery due to its role in infective endocarditis (IE). It is noteworthy that there is
no vaccine or anti-adhesive drug approved against IE. Hence, it is important to use
chemical biology approaches to identify and describe how small molecules could
inhibit the adhering function of the protein, which may, down the road, open the
door to drug discovery. Here, we performed structure-based virtual screening to
identify competitive small molecule effectors for Hsa BR. We combined three
different SBDD strategies; ensemble docking, cross screening, and consensus
scoring in one pipeline. For the ensemble docking, we generated an ensemble of
receptor conformations from MD simulation, and then cross screened against five
homologs (GspBBR, 10712BR, SK150BR, SrpABR, SK678BR). In the last step, three
scoring functions (AutodockVina89 and MOE86) were used to rank and prioritize the
list of compounds. The Vanderbilt database was used for the small molecules
since it covers a wide distribution of different physicochemical properties.
The goal of combining these strategies was to improve the hit rate and
reduce the number of false positives. Indeed, we were able to achieve a hit rate of
~20% and identified nine compounds that could displace the native ligand in the
experimental assay. The binding poses of all the nine compounds identified from
docking show that they are in close proximity with residues known to form HBs
with the native ligand (sialyl-T antigen). These compounds may be used as a
starting point for medicinal chemistry optimization. Further studies need to be
conducted to characterize the binding affinities and poses of these identified
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compounds, and similar analyses for other sialoglycan-binding SRR proteins are
ongoing.
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5.1.6 Appendix

Create ensemble of
structure from MD
simulations

Dock ~105K compounds in
the adhesin sialoglycan
binding pocket using
VinaMPI

Rank the compounds
based on the
AutodockVina scoring
function

~105K

Rank the compounds
based on consensus scoring

Refine and rescore these
compounds using MOE
scoring function
(GBVI-WSA dG and
Affinity dG)

250

Take top 1% of
compounds calculated to
binds to Hsa but not in top
1% of other adhesin
proteins
(GspBBR,10712BR,SK150BR,
SrpABR,SK678BR)

50
Experimental validation

Figure 5.1 Structure based virtual screening strategy workflow showing
number of compounds which were passed on to the next step.
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Figure 5.2 a) Root mean square fluctuation of Hsa BR from MD simulation
showing DC, EF, FG loop regions; b) Superimposed structures (in ribbon) of
HsaBR obtained from different clusters showing residues (in stick) used to
during the clustering: crystal structure (in red) and ensemble structure (in
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database: molecular weight (a), number of rotatable bonds (b), polar surface
area (c), and Log of the octanol/water partition coefficient: SLogP (d).

136

b)

# of compounds

a)

acidic
basic
polar
greasy

Sidechain
acceptor/donor

# of interactions with residues

Backbone
acceptor/donor
Ligand
exposure

Figure 5.4 a) Interaction map of native ligand (sTa) from crystal structure
(PDB 6EFD)198; b) Bar plot showing number of compounds (within the top 50
compounds) and the number of interactions (Hbond or Pi (π-π/π-H/π-cation)
made with protein residues
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Figure 5.5 Alpha Screen assay. Experimentally validated effectors are
marked by green boxes on the x-axes. Error bar represent the standard
deviation.
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Figure 5.8 Hierarchical clustering based on MACCS fingerprint of the nine
validated hits and the native ligand
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Figure 5.9 Crystal structure pose of native ligand (sTa) (in red) and best
docked pose of 9 validated compounds (in blue) in the binding pocket of
HsaBR
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Figure 5.10 Number of compounds within the top 50 compounds interacting
(forming Hbond or Pi (π-π/π-H/π-cation) interaction) with key residues in the
HsaBR binding pocket
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Figure 5.11 Interaction map of the nine hits in the binding pocket of the
HsaBR
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Figure 5.11 continued
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Figure 5.11 continued
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Figure 5.11 continued
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Table 5.1 Structure of the nine hits and interaction details in the binding
pocket of the HsaBR

ID

Protein residues
forming
Backbone HBs

Protein residues
forming
Sidechain HBs

C1

VU0079850

255

285,337,367

C2

VU0284203

255,367

361,367

C3

VU0490742

362,366,367

253,337, 339

C4

VU0645728

255,367

255,337,341,356

C5

VU0514818

255, 362

285,339,340,356
,361,367

C6

VU0534073

-

255,285,339,361
,365,367

C7

VU0617926

-

285,337,339,340
,356,365,367

C8

VU0617940

362

285,337,339,367

C9

VU0624167

285

339,340,361,365
,367

Compound
number

Structure
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Table 5.2 Residues included during clustering of MD simulation snapshots
to form an ‘ensemble’
Protein

Residues

HsaBR

285-295, 333-343, 356-365

SK678BR

297-307, 342-352, 366-376

SrpABR

288-298, 338-348, 363-368

10712BR

286-299, 335-345, 355-366

GspBBR

437-447, 477-487, 503-510

SK150BR

296-306, 336-346, 356-366

Table 5.3 Validated compound list with their respective percentage control
Test compound
(1x) conc (nM)

Compound
Name

Percentage
control

10000

VU0490742

70%

10000

VU0514818

68%

10000

VU0624167

65%

10000

VU0534073

64%

10000

VU0617940

64%

10000

VU0079850

63%

10000

VU0617926

41%

10000

VU0284203

35%

10000

VU0645728

23%
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5.2 Disruption of histone deacetylases 4 (HDAC4)
complexation by novel selective inhibitors
5.2.1 Abstract
Histone deacetylases (HDACs) are a biologically important family of proteins which
also comprise known cancer drug targets. Currently, there are several FDA
approved drugs that target the catalytic pocket of HDACs, which is conserved
within the family, and hence are not selective towards a particular subfamily of
HDACs. This non-selectivity leads to off-site binding and toxicity. HDAC4 belongs
to one such subfamily of HDACs (class IIA HDAC), and has been linked to the
development of multiple cancers (Prostate, colon, ovarian, and gastric); however,
there are no known inhibitors that bind specifically to HDAC4. Since the catalytic
pocket in HDACs is conserved, using the currently available inhibitors invariably
targets other HDACs and potentially causes toxicity. Hence to specifically target
HDAC4, here we employed a new strategy to inhibit HDAC4 by disrupting its
complexation with the nuclear receptor co-repressor (NCoR), which is critical for
its function. Using classical and accelerated molecular dynamics (MD) simulations,
we identified novel pockets in the protein-protein interface, which are not present
in the available crystal structures. These pockets were then targeted using an
ensemble docking approach combined with consensus scoring. Using this
approach, we were able to identify 9 novel hits out of 45 suggested compounds
(hit rate 20%), which successfully inhibited the catalytic activity of HDAC4 in an invitro assay. Out of these 9 hits, 3 compounds were found to be selective towards
HDAC4 when compared to HDAC3, which belongs to a different family of HDACs
(class I).
5.2.2 Introduction
Histone deacetylases (HDACs) catalyze the deacetylation of histone tail lysines,
resulting in the compaction of DNA and hence the suppression of transcription343.
HDAC enzymes works in opposition to Histone acetyltransferases (HAT), which
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transfer an acetyl group to lysine in histone tail, and enhance transcription344. In a
normal cell, the transcription levels regulated by HATs and HDACs are well
balanced343. However, abnormality in the function of HDACs has been reported to
contribute to the initiation and progression of several tumors 343. Specifically,
irregularity in HDAC function can cause abnormal transcription of critical genes
that control vital cell functions, namely proliferation, cell cycle regulation, and
apoptosis345, 346. HDACs have also been thought to play a role in several other
important genomic functions such as DNA repair, chromatin assembly, and
recombination347. Hence, given their role in cellular proliferation, HDAC inhibitors
have emerged to be important drugs for cancer therapy, as they can suppress
abnormal histone deacetylation leading to normal levels of acetylated histones 348.
To date, four HDAC inhibitors: Vorinostat (SAHA), Romidepsin (FK-228),
Belinostat (PXD-101), and Panobinostat (LBH-589) have been granted US FDA
approval for cancer treatment and many other HDAC inhibitors are currently in
various phases of clinical trials349, 350. All these US FDA approved HDAC inhibitors
target the catalytic pocket region and share common structural features that
comprise a metal-binding moiety, a linker region, and a surface recognition
domain350,

351

. The catalytic pockets in HDACs, however, is evolutionarily

conserved among all zinc-dependent HDACs, thus explaining why these inhibitors
are nonspecific binders350 and leads to off-site binding causing and hence toxicity.
Hence for the structure-based design of specific inhibitors, there is a need to focus
on the structural differences between HDACs and move away from the current
strategies350.
HDACs have been divided into four major classes based on their catalytic
mechanisms and sequence homology: Class I (HDAC 1, 2, 3, 8), IIa (HDAC 4, 5,
7, 9), IIb (HDAC 6, 10), III, and IV (HDAC 11)352. All these HDACs, excepting class
III, have a zinc (Zn+2) ion in the catalytic pocket for the enzymatic activities,
whereas class III HDACs or sirtuins353 require nicotine adenine dinucleotide as a
cofactor. HDACs cannot bind to DNA by themselves and exist as components in
a variety of multiprotein complexes (HDAC1 and HDAC2 are found in three distinct
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corepressor complexes, called SIN3A354, NURD/Mi2355 and CoREST, and HDAC3
is found in SMRT/NCoR complexes356). Although characterized as HDACs, class
IIa enzymes lack deacetylase activity because a key tyrosine residue, which
stabilizes the tetrahedral intermediate during deacetylation of the native substrate
(acetylated lysine) is absent357. The catalytic domain contains two zincs: structural
and catalytic. Structural zinc is one of the distinguishing features of Class IIa from
Class I HDACs; it holds together the two loops, whereas catalytic zinc performs
the deacetylation mechanism. Hence, it is believed that class IIa HDACs,
especially HDAC4, function by forming multiprotein complexes with other
enzymatically active class I HDACs. HDAC4 forms a complex with HDAC3-NCoR
and is believed to operate as a scaffold for the recruitment of multiprotein
complexes, thus increasing the range of deacetylation in specific regions of
chromatin358.
HDAC4 has been implicated in promoting tumor growth through the suppression
of p21 expression in colon cancer, glioblastoma, ovarian cancer, and gastric
cancer cells359 and therefore is a potential drug target for anti-cancer therapy.
However, there are no known inhibitors that target HDAC4 selectively. Here, we
used a structure-based drug discovery approach to identify novel inhibitors that
selectively bind to HDAC4, which is an appropriate approach in this case since
there are two reported crystal structures of HDAC4 catalytic domain in the open
and closed conformations357. In the open conformation, HDAC4 is bound to an
inhibitor at the catalytic pocket, whereas in the closed conformation, there is a gain
of function mutation of H332Y. The two loops bound to its structural zinc are closer
to the active site in the closed conformation, making it different from the open
conformation. Most of the enzymatic activity associated with HDAC4 expressed
has been reported to be due to endogenous HDAC3. HDAC4 can shuttle between
cytoplasm and nucleus and can bind to NCoR, which is also bound to
enzymatically active HDAC3360. It has been previously reported that HDAC4 binds
to the repression domain 3 (RD3) of NCoR whereas, HDAC3 binds to SANT
domain of NCoR356, 360. There are, however, no structures of the HDAC4-NCoR
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complex; but based on mutational studies performed by Kim et al 361, 21 “hot spot”
residues (C667, C669, C751, D759, T760, S767, A774, P799, P800, G801, H803,
A804, F812, C813, H842, H843, G844, N845, G846, G868, and F871) present on
the surface of HDAC4 have been identified as the residues that prevent its binding
to the NCoR-HDAC3 complex in vivo (Fig 5.12). These interfacial residues are
conserved across all class IIa HDACs, while some of these residues (C667, C669,
C751, D759, T760, and F871) are only found in class IIa HDACs and not in class
I, which form the basis for their interaction specificity with NCoR.
With this knowledge, our strategy was to focus on the HDAC4 interface with NCoR
rather than targeting the catalytic pocket. Protein-protein interfaces (PPIs) have
emerged as a major drug target since a large number of proteins critical in
biological pathways related to various diseases, function after complex
formation362. Although PPIs are promising drug targets, there are major challenges
in targeting interfaces since they mostly lack cavities for small molecules to bind
or are intrinsically disordered363. Nevertheless, it has been shown that small
molecules are capable of interacting at the position of “hot-spots” and compete
with the binding of the target’s cognate partner without necessarily covering the
entire PPI surface. In this study, we have used classical molecular dynamics (MD)
simulation and enhanced sampling method accelerated molecular dynamics
(aMD) simulation approaches to generate an ensemble of structures and to identify
potential pockets in the experimentally characterized interface of HDAC4 and
NCoR. aMD samples the conformational space more efficiently compared to MD,
which results in receptor conformers, which would not have been sampled in a
short time classical MD. Unlike other enhanced sampling methods, aMD does not
require reaction coordinates or collective variables and is well suited for creating
an ensemble of structures to characterize the conformational flexibility of a
receptor. Using these techniques, we have identified novel pockets in the PPI
which were not present in the crystal structures. These pockets have not been
reported before, and we hypothesized that small molecules binding in these
pockets would lead to disruption of the complex formation with NCoR. We thus
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performed high throughput in silico screening of small molecule databases on the
ensemble of structures targeting these newly identified pockets. Furthermore, we
identified forty-five compounds that were predicted to bind HDAC4 in these
pockets, of which nine were validated experimentally to bind HDAC4, and out of
these nine, at least three compounds were selective towards HDAC4 over HDAC3.
5.2.3 Methods
System preparation
Crystal structures of HDAC4 in the open (PDB 2VQM) 357 and in the closed states
(PDB 2VQW)357 were used for this study. Both the protein structures and water
molecules were modeled using Amber ff14SB parameters 58,
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. Using xleap,

cysteines 667, 669, and 751 were deprotonated (-ve charge) and converted to
CYM for closed conformation and cysteines 667 and 751 were converted to CYM
for open conformation since they coordinate structural zinc in respective crystal
structures. The open structure was crystallized in the presence of an inhibitor,
which was deleted for the simulation. The closed structure was crystallized with a
mutation H332Y, and so the tyrosine was mutated to wild type histidine for the
simulation. The protein was surrounded by an octahedral box of water model
TIP3P box of 10 Å.
Classical molecular dynamics simulation
Molecular dynamic (MD) simulations were performed on both the crystal
structures. First, the HDAC4 structure was held fixed with force constant of 500
kcal mol-1 Å-2 while the system was minimized with 500 steps of steepest descent
followed by 500 steps with the conjugate gradient method. In the second
minimization step, the restraints on HDAC4 were removed, and 1000 steps of
steepest descent minimization were performed, followed by 1500 steps of a
conjugate gradient. The system was heated to 300 K while holding the protein fixed
with a force constant of 10 kcal mol -1 Å-2 for 1000 steps. Then, the restraints were
released, and 1000 MD steps were performed. The SHAKE algorithm was used to
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constrain all bonds involving hydrogen in the simulations. A 50 ns MD was
performed at 300 K using the NPT ensemble and a 2 fs time step. This procedure
yielded a total of 250,000 snapshots for subsequent analyses.

Accelerated molecular dynamics simulation
The aMD simulation was performed by using a dual energy boost (i.e. Dihedral
energy and Potential energy) with acceleration parameter (α) of 0.2. The average
total potential energy and average dihedral energy parameters for aMD were
calculated from the classical MD simulations. We performed 100 ns of accelerated
MD (aMD) simulation. This procedure yielded a total of 500,000 snapshots for
subsequent analyses. Snapshots from classical MD and aMD were clustered by
root mean square deviation (RMSD) of hot spot residues with the hierarchical
agglomerate clustering algorithm present in the CPPTRAJ module204.
In silico screening
We generated an ensemble of 4 representative snapshots (RS) each from
classical MD and aMD for both open and closed conformations. NCI Diversity V
(~1600 compounds)364 was docked to a total ensemble of 9 receptors (4 RS from
MD, 4 RS from aMD and 1 crystal structure) with a cubic box size of ~30 Å.
VinaMPI324, a parallel version of AutodockVina90, was used to perform the in silico
screening. The docked poses were then ranked by AutodockVina scoring
function89. The compound list was further narrowed by excluding compounds that
were within 10 Å of the catalytic zinc. From this narrowed list, the top 45 ranked
compounds were taken for experimental testing. The steps followed for ensemble
docking are shown below in schematic (Fig. 5.13)

Experimental validation
The experimental validation was performed by Dr. Michael Duff at the University
of Tennessee.
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HDAC3 and HDAC4 activity assays were performed using fluorogenic assay kits
obtained from BPS Bioscience (San Diego, CA). Compounds were prepared as 10
mM stocks in DMSO and were screened at 100 μM in the assays.
The activity of the enzymes in the absence and presence of compounds was
measured on a BioTek Cytation 5 plate reader, exciting the samples at 350 nm
and measuring emission at 450 nm. IC50 values were determined for the
compounds that decreased HDAC activity by at least 25% relative to no inhibitor.
5.2.4 Results and Discussion
Novel pockets in the PPI
The PPI residues on HDAC4 are present in the region between the catalytic pocket
and the structural zinc. In the crystal structures, this region is smooth and there
are no druggable cavity present for a small molecule to bind, which is generally a
major drawback of targeting PPI of complexes. In our ensemble of receptor
structures generated from classical MD and aMD simulations for both open and
closed conformations, we identified novel cavities in the PPI which were not
present in the crystal structures (Fig 5.14. 5.16). These cavities were present in
the “hot-spot” region and contained a cavity for small molecules to bind.
In the snapshots for closed structures generated from simulations, we observed
some shallow cavities (Fig 5.14 c, d), and a deep pocket (~14 Å) near the
structural zinc which were present in the PPI as shown in Figs 5.14 and 5.16. The
opening of this novel pocket was located between the two loops with the residues
(T668, H675, P676, C751, D759, T760) forming the gate of the pocket (Fig 5.15a).
The distances between these residues were measured for the trajectory. The
fluctuation in the width of the opening of this pocket has been shown by a
probability distribution (Fig 5.15b). In the ensemble of the open structures, there
were snapshots with an extended cavity with depth ~9 Å in the PPI region. This
cavity extends ~16 Å from the tip of the catalytic pocket to the structural zinc (Fig
5.15). These pockets are important since they stretch throughout the PPI region.
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These results emphasize the power of docking to an ensemble of structures as
compared to traditional screens to only the crystal structure.

Virtual screening
The docking search box was made big enough to include the catalytic pocket as
well as the region identified as PPI. The aim of this approach was to identify
compounds that bind with a higher score in the PPI, even in the presence of a
hydrophobic catalytic pocket. In our final list of compounds, we excluded all the
compounds within 10 Å of the catalytic zinc and only included those compounds
whose best docked poses were present in the PPI. We found small molecules that
bound in the novel pockets discovered in the PPI (Figs 5.14, 5.16). After carefully
examining the binding poses and sites, we picked 45 compounds that were able
to bind in these different binding pockets. These compounds were then suggested
for experimental validations.

Experimental validation
Compounds were screened for their ability to inhibit HDAC4 and their potential
selectivity against HDAC3 (from a different HDAC subfamily) was also tested
(Figure 5.19). Two compounds (67436 and 134199) decreased both HDAC3 and
HDAC4 activities to 40%, or less, compared to the control condition without any
inhibitor. A few of the compounds were specific towards only one of the two
enzymes tested. HDAC4 was significantly inhibited by 88402 (<40% activity
retained), while HDAC3 activity was only mildly perturbed (75% activity relative to
no inhibitor). Compounds 34488, 44584, and 195327 decreased HDAC3 activity
50%, 60%, and 80%, respectively, while HDAC4 activity remained unchanged in
the presence of those compounds (Figure 5.19).
The compounds that decreased the activities of the HDAC4 by at least 25% were
further screened for IC50 values (Table 5.4). Compounds 67436 and 134199 had
IC50 values in the low micromolar range for both HDACs, which was comparable
to that of previously known inhibitors of HDAC4, trichostatin A and SAHA.
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Interestingly, both these compounds were significantly weaker inhibitors of HDAC3
compared to trichostatin A and SAHA. The seemingly HDAC4-specific inhibitors
88402, 299968, and 319435 had IC50 values 2-fold lower for HDAC4 compared
to that for HDAC3. The latter two compounds did not inhibit HDAC3 appreciably at
a concentration of at least 500 μM, indicating that they could not inhibit HDAC3.
The other compounds that weakly inhibited HDAC4 (4135, 36425, and 51936) had
IC50 values not much lower than the highest concentration used in the assay (500
μM) and may not be significant inhibitors of either enzymes. From these results,
we identified 9 compounds that could bind to HDAC4 and to inhibit its deacetylase
activity in the assay. Out of these 9, 3 compounds were selectively inhibitory to
HDAC4 when compared to HDAC3.
5.2.5 Conclusions
Histone deacetylase 4 (HDAC4) is a drug target for multiple cancers; however, all
the FDA approved drugs that target HDACs are pan inhibitors and hence are not
selective towards a specific sub-family. All these known inhibitors bind in the
conserved catalytic pocket. Therefore, there is a need to find inhibitors selective
for HDAC4. Since the catalytic pocket is conserved, selectivity is difficult to achieve
by identifying small molecules that bind in the catalytic pocket by chelating the
catalytic zinc. Hence, in this study, we moved away from the common strategy of
targeting the catalytic pocket and focused on the protein-protein interface of
HDAC4 with NCoR. This complexation is considered critical for HDAC4 function
and disrupting it can lead to functional inhibition. Since the HDAC4 crystal
structures had smooth PPI with no cavities/pockets that could be targeted by small
molecules, we performed classical and enhanced sampling MD simulations to
identify different conformations of the PPI. Indeed, we were able to identify pockets
in PPI region which had not been characterized before and were not present in
either of the crystal structures used. Using ensemble docking, we targeted these
novel pockets in the PPI region. To further improve the hit rate and reduce the
number of false positive, we used a consensus scoring scheme.
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By combining computational and experimental methods, we were able to identify
nine compounds (hit rate 20%) that were able to bind HDAC4 and inhibit its
catalytic activity. Further experimental validations showed that out of these nine,
three compounds could selectively inhibit to HDAC4 when compared to HDAC3
(from class I HDAC family). These compounds are currently being tested with
Prostate and Breast cancer cell lines to measure their cell-killing activity. Moreover,
these compounds can also be used as a starting point for medicinal chemistry
optimization.
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5.2.6 Appendix

Figure 5.12 Crystal structure of open conformation357 (a & b) and closed
conformation357 (c & d). The red sticks and red region represent residues
identified as the “hot spot” residues identified previously 361; black sphere
represents the two zincs (catalytic & structural). a & c are ribbon model of
the crystal structures, and b & d are surface model.
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Figure 5.13 Schematic diagram explaining the ensemble docking strategy
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Figure 5.14 Closed conformation representative snapshots generated from
simulations of crystal structures. Red sticks represent “hot spot” residues,
and blue mesh represents pockets in & near the PPI region. a) Crystal
structure and b, c, d) Snapshots from aMD and MD simulations.
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Figure 5.15 The novel pocket discovered in the close conformation (as
shown in Figure 3b). a) The pocket is shown in blue mesh with residues in
the two loops, which are present in the gate of this pocket, b) probability
distribution of the distance of the residues.

Figure 5.16 Open conformation representative snapshots generated from
simulations. Red sticks represent “hot spot” residues, and blue mesh
represents pockets in & near the PPI region. a) Crystal structure and b)
Snapshot generated from simulations.
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Figure 5.17 Top-ranked hits bound a) closed conformation and b) open
conformation snapshot
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Figure 5.18 Top-ranked hits bound a) closed conformation and b) open
conformation snapshot
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Figure 5.19 Effect of compounds on the activities of HDACs. The relative
percent activity of HDAC3 (blue bars) and HDAC4 (red bars) in the presence
of 100 μM inhibitor compound compared to the absence of inhibitor. Error
bars are the standard deviation of at least two assays.

Table 5.4 IC50 values for compounds that inhibited HDAC3 and HDAC4
(Selective inhibitors shown in green and Known inhibitors shown in Yellow)
Compound

IC50 (μM) for HDAC3

IC50 (μM) for HDAC4

Trichostatin A

0.011 ± 0.002

1.5 ± 0.8

SAHA

0.024 ± 0.006

25±13

4135

>500

410 ± 240

36425

>500

480 ± 260

51936

>500

550 ± 350

67436

9.2 ± 5.2

47±28

88402

210 ± 60

100±40

134199

25 ± 7

33±12

299968

>500

250 ± 170

319435

>500

150 ± 50
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6 CONCLUSIONS AND FUTURE DIRECTIONS

167

6.1 Conclusions

The motivation behind the work described in this thesis was: i) to develop a novel
method to accurately parameterize small deuterated molecules for classical MD
simulations; ii) to characterize the role of global and local motions in the function
of adhesin proteins; iii) to examine the effect the temperature and pressure in the
catalytic pocket of thermophilic inorganic pyrophosphatases and how it differs from
its mesophilic homolog; iv) to identify novel inhibitors against two clinically relevant
protein targets (Hsa and HDAC4). These goals were achieved using a combination
of computational biophysics and experimental methods. The major contributions
of the work are summarized below.

In Chapter 2, I demonstrated that classical MD simulations using the CHARMM
forcefield contain implicit isotopic biases. I also demonstrated that careful reparameterization of the forcefield parameters to account for the “proper” isotopic
bias permitted the construction of new forcefield parameters, which can accurately
represent isotopic substitutions using classical MD simulations (in the absence of
nuclear quantum effects). In addition, MD simulations with these new forcefield
parameters provided detailed molecular insights into the origin of the loss of the
THF-water miscibility gap upon the complete deuteration of THF. These results
indicated that upon deuteration, the intramolecular interactions within THF are
modified, which changes the structure of the molecule and allows for an increase
in the formation of THF-water hydrogen bonds. These new inter-molecular
interactions then compensate for the overall reduction of favorable THF-water
interactions upon heating and prevent D 8THF and water from phase separating,
thus eliminating the miscibility gap.

In Chapter 3.1, I performed extensive MD simulations on the first crystal structures
of HsaBR bound to Neu5Ac-Gal and Neu5Gc-Gal. I was able to provide insights
into the mechanism behind the dual specificity of HsaBR adhesins towards the
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commonly found sialic acids, Neu5Ac and Neu5Gc. Here, I demonstrated that
HsaBR is able to bind Neu5Gc even in the absence of a specific tyrosine residue
(present in SrpABR), which had previously been considered essential for binding
Neu5Gc. Furthermore, I also demonstrated that the additional C11-OH group of
Neu5Gc does not form a direct interaction with the residues in Hsa BR, which seems
to be the primary reason preventing its preferential binding to Neu5Gc. I also found
that HsaBR did not have specific hydrophobic residues (Ile 479 and Thr 478) like
GspBBR, which are considered important for making GspBBR selective towards
Neu5Ac. Taken together, I uncovered that adhesin Hsa lacks the features present
in the selective adhesins (GspBBR and SrpABR). The results suggest a potential
mechanism behind the observed dual specificity in Hsa towards both the sialic
acids. Moreover, this study also provided insights behind the selectivity of GspBBR
and SrpABR adhesins towards Neu5Ac and Neu5Gc, respectively.
In Chapter 3.2, I have studied SRR adhesin proteins (especially GspB), which are
present on the surface of streptococci and staphylococci. The adherence of the
adhesin proteins (present on the bacteria) to the host platelet cells has been known
to be critical for the pathogenesis of a cardiovascular disease called infective
endocarditis. In our study, I have combined biochemical and computational
approaches to reveal that the orientation of these adhesin proteins, specifically the
binding pocket, is critical for the binding to the host platelet cells and that a slight
change in the native orientation can cause significant reduction in the binding to
the platelets. Additionally, I have also demonstrated that the Unique domain in
these SRR adhesin proteins does not affect the binding pocket but plays an
important role in maintaining the required rigidity in the inter-domain so as to retain
the binding pocket orientation.

In Chapter 4, I have compared the structural and dynamic properties of two
pyrophosphatases- a hyperthermophilic (TtPPase) and a mesophilic (EcPPase)
pyrophosphatase using MD simulations mimicking both deep-sea and ambient
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conditions. The results of this study indicated that TtPPase has been “designed”
to function at high temperatures and exhibits a comparatively more compact
structure with reduced number of intra-protein hydrogen bonds in the catalytic
pocket. However, simulations of TtPPase at its non-native conditions revealed that
it fails to preserve both of these properties at room temperatures, and thus
becomes enzymatically inactive. Interestingly, I found that on the contrary,
EcPPase adapts and retains its activity at high temperatures by incorporating the
strategies used by TtPPase to function at high temperatures.

In Chapter 5.1, I performed structure-based virtual screening to identify
competitive small molecule effectors against HsaBR. I have combined three
different SBDD strategies: ensemble docking, cross screening, and consensus
scoring in one pipeline. For ensemble docking, I generated an ensemble of
receptor conformations from MD simulations, and also performed cross screening
against five other homologs (GspBBR, 10712BR, SK150BR, SrpABR, SK678BR). In the
last step, three scoring functions (AutodockVina and MOE) were used to rank and
prioritize the list of compounds obtained after ensemble docking and crossscreening. The Vanderbilt database was used for the small molecules since it
covers a wide distribution of different physicochemical properties. The goal of
combining these strategies was to improve the hit rate and reduce the number of
false positives. Indeed, I was able to achieve a hit rate of ~20% and identified nine
compounds that could displace the native ligand in experimental assays. The
binding poses of all the nine compounds identified from docking reveal that they
are in close proximity of the residues known to form hydrogen bonds with the native
ligand (sialyl-T antigen). These compounds may be used as a starting point for
medicinal chemistry optimization.

In Chapter 5.2, I targeted histone deacetylase 4 (HDAC4), which is a cancer drug
target. All the FDA approved drugs that target HDACs are pan inhibitors and hence
are not selective towards a specific sub-family. All these known inhibitors bind in
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the conserved catalytic pocket. Therefore, there is a need to find selective
inhibitors selective for HDAC4. Since the catalytic pocket is conserved, selectivity
is difficult to achieve by identifying small molecules that bind in the catalytic pocket.
Hence, in this study, we moved away from the common strategy of targeting the
catalytic pocket and focused on the protein-protein interface (PPI) of HDAC4 with
NCoR. This complexation is critical for protein function and disrupting it can lead
to inhibition. However, the PPI interface present in the crystal structures are
smooth and do not contain any cavities/pockets that can be targeted by small
molecules. Therefore, I performed classical and enhanced sampling MD
simulations to identify different conformations of the PPI. Indeed, I was able to
identify pockets in PPI region which have not been characterized before and are
not present in either of the crystal structures. Using ensemble docking, we targeted
these novel pockets present in the PPI region. To further improve the hit rate and
reduce number of false positive, we used a consensus scoring scheme.
By combining computational and experimental methods, I was able to identify nine
compounds (hit rate of 20%) which bind to HDAC4 and inhibit the catalytic activity.
Furthermore, three compounds (out of the nine) can selectively inhibit HDAC4
when compared to HDAC3 (from class I HDAC family).
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6.2 Future directions
The work done in this thesis has contributed to the field of computational
biophysics, drug discovery, protein evolution, and dynamics. The findings
described in this thesis also generate more ideas which can be extended with
additional computational and experimental studies. Below is a brief list of potential
ideas and some interesting research topics, which are worth investigating further.

The success of reparameterization approach to accurately capture deuteration
effect shown in Chapter 2 suggests that a similar methodology may be
implemented in MD simulations of other deuterated systems. The methodology
presented here can be employed in a drug discovery pipeline of small deuterated
molecules that are of growing importance as pharmaceuticals 174, 175, especially
since the first deuterated drug Austedo (deutetrabenazine), from Teva, was FDA
approved in 2017 to target Huntington’s chorea365. Additionally, accurate modeling
of the small deuterated molecules will also be critical to target a protein/RNA/DNA.
Moreover, this methodology can serve as an aid in the interpretation of
experiments such as NMR176 and neutron scattering177 where isotope substitution
is of critical importance.

The local loop motion in the binding pocket of adhesin proteins provided an insight
into the binding mechanism of different glycan molecules. The binding of adhesin
proteins to platelet glycans is known to be critical for infective endocarditis.
Therefore, knowing the binding of the native glycan ligands to these adhesins can
lead to new strategies to target the protein. A series of mutagenesis experiments
and simulations can be performed to further validate some of the predictions made
in Chapter 3.1. Moreover, adhesin proteins have also been considered as probes
to detect sialoglycans that are presented on the surfaces of cancer cells as
potential biomarkers. Knowledge obtained from this study can further be used to
engineer the binding pocket to make these adhesin proteins selective towards
particular sialoglycans for use as biomarkers. Additionally, we showed that the
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binding pocket orientation of adhesin protein on the surface of the bacterial cell is
important in Chapter 3.2. This knowledge can also be used as a novel strategy to
target adhesin proteins. Moreover, a similar study should be performed for other
adhesin proteins and surface proteins to explore if structural domain rigidity and
precise orientations are conserved.

The effect of non-native condition on mesophilic and thermophilic inorganic
pyrophosphatase homologs was studied in Chapter 4. To take this work further,
experiments like mutagenesis and measurement of enzymatic activities can be
performed to validate the predictions made using MD simulations. We introduced
a potential mechanism on how a mesophilic enzyme is more adaptive and can
function at both low and high temperatures. This mechanism can be tested on
other homologous pairs to evaluate if it is widespread or if it is unique for these
particular type of proteins. Moreover, further study can be done to understand the
effect of solvation on the dynamics of proteins.

Lastly, we have identified nine novel competitive hits that target the adhesin protein
Hsa in Chapter 5.1. Further studies need to be conducted to characterize the
binding affinities and poses of these identified compounds and similar analyses
can be performed for other sialoglycan-binding SRR proteins. With the known hits,
the plausible next step would be to crystalize them with the protein and perform
more rigorous free energy calculations before moving to the next step of lead
optimization. Another possible step is to experimentally test for the selectivity of
these nine hits against other human and bacterial sialoglycans binding proteins. In
the case of HDAC4, we have identified hits that are selective and potentially do not
bind in the catalytic pocket as described in Chapter 5.2. The next steps would be
similar to those for Hsa. In addition, these selective compounds should be
screened against various cancer cell lines. Since in this study I was able to
potentially find novel compounds which do not bind in the conserved catalytic
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pocket, the novel scaffold can also be further explored to find more hits (i.e., hit
expansion).
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